10-Q/A - CLRCF - Equibles

UNITED

STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q/A

(AmendmentNo. 1)

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For

the quarterly period ended September 30, 2022

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For

the transition period from _____ to _____

Commission

File No. 001-41363

CLIMATEROCK

| (Exact name of registrant as specified in its charter) |

Cayman Islands	N/A

| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

50 Sloane Avenue<br> <br>London, SW3 3DD, United Kingdom

| (Address of Principal Executive Offices, including zip code) |

+44 203 954 0590

| (Registrant’s telephone number, including area code) |

N/A
(Former<br> name, former address and former fiscal year, if changed since last report)

Securities

registered pursuant to Section 12(b) of the Act:

Titleof each class	Trading Symbol(s)	Name of each exchange on which registered

| Units, each consisting of one Class A Ordinary Share, one-half of one Redeemable Warrant and one Right | CLRCU | The Nasdaq Stock Market LLC |

| Class A Ordinary Share, par value $0.0001 per share | CLRC | The Nasdaq Stock Market LLC |

| Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 | CLRCW | The Nasdaq Stock Market LLC |

| Rights, each entitling the holder to receive one-tenth (1/10) of one Class A Ordinary Share upon the consummation of an initial business combination | CLRCR | The Nasdaq Stock Market LLC |

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐<br>Large accelerated filer	☐ Accelerated filer

| ☒ Non-accelerated filer | ☒ Smaller reporting company |

| | ☒ Emerging growth company |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of December 21, 2022, there were 7,993,125 Class A ordinary shares, par value $0.0001, and 1,968,750 Class B ordinary shares, $0.0001 par value, issued and outstanding.

EXPLANATORY

NOTE

ClimateRock (the “Company,” “we,” “us” or “our”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q/A for the quarterly period ended September 30, 2022 (this “Amended Quarterly Report”) to amend and restate certain terms in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 originally filed with the Securities and Exchange Commission (the “SEC”) on November 9, 2022 (the “Original Quarterly Report”).

Background of Restatement

On November 9, 2022, ClimateRock (the “Company”) filed the Original Quarterly Report. As described in Note 2, Management identified errors made with respect to its recording and accrual of certain expenses. Specifically, in the third quarter of 2022, the Company incurred legal expenses with two vendors related to the Business Combination Agreement (as defined below). The service was delivered throughout the third quarter of 2022, but the fees were not properly recorded in accordance with U.S. Generally Accepted Accounting Principles.

On December 20, 2022, the Company’s management, together with the audit committee of the Company’s board of directors (the “Audit Committee”), concluded that the Company’s previously issued unaudited interim financial statements included in the Original Quarterly Report should no longer be relied upon due to certain errors made in the recording and accruing of the above-referenced expenses for such reporting period.

The restatement does not have an impact on the Company’s cash position and cash held in the trust account established in connection with the Company’s initial public offering (the “Trust Account”).

The financial information that has been previously filed or otherwise reported for the period ended September 30, 2022 is superseded by the information in this Amended Quarterly Report, and the financial statements and related financial information contained in the Original Quarterly Report should no longer be relied upon. On December 21, 2022, the Company filed a Current Report on Form 8-K disclosing the non-reliance on the financial statements included in the Original Quarterly Report.

The restatement is more fully described in Note 2 of the notes to the condensed financial statements included herein. The following items have been amended to reflect the restatements:

Part I, Item 1, Financial Statements,

Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations,

Part I, Item 4, Controls and Procedures, and

Part II, Item 1A, Risk Factors.

The Company has also chosen to disclose certain commitments with its financial advisors, ALANTRA Corporate Finance, S.A.U. (“ALANTRA”) and Maxim Group LLC (“Maxim”). This has no impact to the Company’s historical or as restated condensed financial statements. The following items have been amended to reflect this disclosure:

Part I, Item 1, Financial Statements,

Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and

Part II, Item 5, Other Information.

In addition, the Company’s Chief Executive Officer and Chief Financial Officer have provided new certifications dated as of the date of this filing in connection with this Quarterly Report (Exhibits 31.1, 31.2, 32.1 and 32.2).

Except as described above, this Quarterly Report does not amend, update or change any other items or disclosures contained in the Original Quarterly Report, and accordingly, this Quarterly Report does not reflect or purport to reflect any information or events subsequent to the Original Quarterly Report. Accordingly, this Quarterly Report should be read in conjunction with the Original Quarterly Report and the Company’s other filings with the SEC. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Original Quarterly Report.

Internal Control Considerations

In connection with the restatement, management has re-evaluated the effectiveness of the Company’s disclosure controls and procedures and internal control over financial reporting as of September 30, 2022. The Company’s management has concluded that, in light of the errors described above, a material weakness exists in the Company’s internal control over financial reporting and that the Company’s disclosure controls and procedures were not effective as a result thereof as of September 30, 2022. Management performed additional analysis as deemed necessary to ensure that the Company’s unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles and intends to implement remediation steps to improve its disclosure controls and procedures and its internal controls over financial reporting. Specifically, the Company intends to work closely with its financial advisors to ensure balances being recorded at each period end represent the accurate amounts the Company owes. For a discussion of management’s consideration of its disclosure controls and procedures, internal controls over financial reporting, and the material weaknesses identified, see Part I, Item 4, “Controls and Procedures” of this Amended Quarterly Report.

CLIMATEROCK

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
Item<br> 1.
	Balance<br> Sheets as of September 30, 2022 (Unaudited) and December 31, 2021	1
	Unaudited<br> Statements of Operations for the Three and Nine months ended September 30, 2022	2
	Unaudited<br> Statement of Changes in Shareholders’ Equity for the Three and Nine Months ended September 30, 2022	3
	Unaudited<br> Statement of Cash Flows for the Nine Months ended September 30, 2022	4
	Notes<br> to the Unaudited Financial Statements	5
Item<br> 2.	Management’s<br> Discussion and Analysis of Financial Condition and Results of Operations	20
Item<br> 3.	Quantitative<br> and Qualitative Disclosures about Market Risk	27
Item<br> 4.	Controls<br> and Procedures	27
PART II - OTHER INFORMATION
Item<br> 1.	Legal<br> Proceedings	28
Item<br> 1A.	Risk<br> Factors	28
Item<br> 2.	Unregistered<br> Sales of Equity Securities and Use of Proceeds	30
Item<br> 3.	Defaults<br> Upon Senior Securities	30
Item<br> 4.	Mine<br> Safety Disclosures	30
Item<br> 5.	Other<br> Information	30
Item<br> 6.	Exhibits	31
SIGNATURE		32

The accompanying notesare an integral part of these financial statements

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CLIMATEROCK

BALANCE SHEET (UNAUDITED)

			December 31, <br> 2021
ASSETS
Current assets:
Cash	363,891		$	—
Prepaid expenses	191,653			—
Deferred offering costs	—			83,343
Investment held in trust account	80,371,576			—
Total current assets	80,927,120			83,343
TOTAL ASSETS	80,927,120		$	83,343
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accrued liabilities	593,668		$	—
Loan payable - related party	180,000			63,073
Deferred underwriting commission payable	2,362,500			—
Total current liabilities	3,136,168			63,073
TOTAL LIABILITIES	3,136,168		$	63,073
COMMITMENTS AND CONTINGENCIES
Class A common stock, 0.0001 par value, subject to possible redemption. 7,875,000 shares at redemption value of 10.21 per share, including dividends earned in trust account	80,371,576		$	—
Total commitments and contingencies	80,371,576			—
SHAREHOLDERS’ (DEFICIT) EQUITY
Class A ordinary shares, 0.0001 par value; 479,000,000 shares authorized; 118,125 issued and outstanding (excluding 7,875,000 shares subject to possible redemption as of September 30, 2022)	12		$	—
Class B ordinary shares, 0.0001 par value; 20,000,000 shares authorized; 1,968,750 and 2,156,250 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively (1)	197			216
Preference shares, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	—			—
Additional paid-in capital	—			24,784
Accumulated deficit	(2,580,833	)		(4,730	)
Total shareholders’ (deficit) equity	(2,580,624	)	$	20,270
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY	80,927,120		$	83,343

All values are in US Dollars.

(1)

The number of ordinary shares issued and outstanding at December 31, 2021 includes an aggregate of up to 281,250 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter does not exercise the over-allotment option. In connection with the closing of the initial public offering and the underwriter’s partial exercise of over-allotment option on May 2, 2022, 93,750 of the founder shares were no longer subject to forfeiture, and 187,500 of the founder shares were forfeited.

The accompanying notesare an integral part of these financial statements

CLIMATEROCK

STATEMENTOF OPERATIONS (UNAUDITED)

	Three Months Ended<br><br> September 30, <br><br>2022<br><br> (As restated)			Nine Months <br><br>Ended<br><br> September 30, <br><br>2022<br><br> (As restated)
Operating expenses
Formation and operating costs	$	761,514		$	1,034,383
Net loss from operations	$	(761,514	)	$	(1,034,383	)
Other income
Unrealized investment income on trust account		353,596			440,326
Total other income	$	353,596		$	440,326
Net loss	$	(407,918	)	$	(594,057	)
Basic and diluted weighted average shares outstanding
Redeemable ordinary shares, basic and diluted		7,875,000			4,384,615
Non-redeemable ordinary shares, basic and diluted		2,086,875			1,992,967
Redeemable ordinary shares, basic and diluted	$	(0.03	)	$	0.85
Non-redeemable ordinary shares, basic and diluted	$	(0.08	)	$	(2.16	)

The accompanying notesare an integral part of these financial statements

CLIMATEROCK

STATEMENT OF CHANGESIN SHAREHOLDER’S EQUITY AS RESTATED (UNAUDITED)

FOR THE THREE AND NINEMONTHS ENDED SEPTEMBER 30, 2022

						CLASS<br> B<br><br> ORDINARY<br><br> SHARES						PREFERENCE<br><br> SHARES				ADDITIONAL			ACCUMULATED			TOTAL<br><br> SHAREHOLDERS’
			AMOUNT			SHARES			AMOUNT			SHARES		AMOUNT		PAID-IN<br><br> CAPITAL			DEFICIT<br><br> <br>(AS<br> RESTATED)			(DEFICIT)<br> EQUITY<br><br> <br>(AS<br> RESTATED)
Balances<br> - December 31, 2021	—		$	—			2,156,250		$	216			—	$	—	$	24,784		$	(4,730	)	$	20,270
Net<br> loss	—			—			—			—			—		—		—			(1,200	)		(1,200	)
Balances<br> - March 31, 2022	—			—			2,156,250			216			—		—		24,784			(5,930	)		19,070
Forfeiture of 187,500 Class B ordinary shares by initial shareholder	—			—			(187,500	)		(19	)		—		—		19			—			—
Sale of 7,875,000 units at 10 per unit in the initial public offering, including over-allotment, net of underwriters’ discount and offering expenses	7,875,000			788			—			—			—		—		73,655,270			—			73,656,058
Issuance of 118,125 underwriter units, including over-allotment	118,125			12			—			—			—		—		946,169			—			946,181
Sale of 3,762,500 warrants in private placement	—			—			—			—			—		—		3,762,500			—			3,762,500
Adjustment<br> to increase Class A ordinary shares subject to possible redemption to maximum redemption value	(7,875,000	)		(788	)		—			—			—		—		(78,388,742	)		(1,628,449	)		(80,017,979	)
Net<br> loss	—			—			—			—			—		—		—			(184,940	)		(184,940	)
Balances<br> - June 30, 2022	118,125			12			1,968,750			197			—		—		—			(1,819,319	)		(1,819,110	)
Adjustment<br> to increase Class A ordinary shares subject to possible redemption to maximum redemption value	—			—			—			—			—		—		—			(353,596	)		(353,596	)
Net<br> loss (As restated)	—			—			—			—			—		—		—			(407,918	)		(407,918	)
Balances<br> - September 30, 2022 (As restated)	118,125			12			1,968,750			197			—		—		—			(2,580,833	)		(2,580,624	)

All values are in US Dollars.

(1)

The accompanying notesare an integral part of these financial statements

CLIMATEROCK

ASRESTATED STATEMENT OF CASH FLOWS (UNAUDITED)

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2022

Cash flows from operating activities:
Net loss (As restated)	$	(594,057	)
Adjustment to reconcile net loss to net cash in operating activities:
Unrealized investment income received in trust account		(440,326	)
Changes in operating assets and liabilities:
Accrued liabilities (As restated)		593,668
Prepaid expenses		(191,653	)
Net cash used in operating activities	$	(632,368	)
Cash flows from investing activities:
Cash deposited in trust account		(79,931,250	)
Net cash used in investing activities	$	(79,931,250	)
Cash flows from financing activities:
Proceed from related party loan		185,150
Repayment of related party loans		(217,641	)
Proceeds from sale of units in the initial public offering, including over-allotment		78,750,000
Payment of underwriting fee and other offering costs		(1,552,500	)
Proceeds from sale of warrants in private placement		3,762,500
Net cash provided by financing activities	$	80,927,509
Net increase in cash	$	363,891
Cash at beginning of period		—
Cash at end of period	$	363,891
Non-cash investing and financial activities:
Deferred offering costs paid by related party	$	149,418
Deferred underwriting commission charged to additional paid in capital		2,362,500
Allocation of offering costs to Class A ordinary shares subject to redemption		304,011
Issuance of representative shares		946,181
Initial value of public shares subject to possible redemption		71,851,500
Reclassification of offering costs related to public shares		(4,647,702	)
Remeasurement adjustment on public shares subject to possible redemption		13,167,778

The accompanying notesare an integral part of these financial statements

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

NOTE

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

ClimateRock (the “Company”) is a Cayman Islands exempted company incorporated as a blank check company on December 6, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company focuses on opportunities in climate change, environment, renewable energy and emerging, clean technologies.

At September 30, 2022, the Company had not yet commenced operations. All activity through September 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and post-offering activities in search for a target to consummate a Business Combination. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s Initial Public Offering was declared effective on April 27, 2022. On May 2, 2022, the Company consummated its Initial Public Offering of 7,875,000 units (“Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit, including 375,000 Units that were issued pursuant to the underwriters’ partial exercise of their over-allotment option, generating gross proceeds of $78,750,000.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,762,500 warrants (“Private Placement Warrants”) at a price of $1.00 per warrant to the Company’s sponsor, U.N. SDG Support LLC, a Delaware limited liability company (“Sponsor”), generating gross proceeds of $3,762,500 (see Note 5).

Offering costs amounted to $5,093,930, consisting of $1,181,250 of underwriting fees, $2,362,500 of deferred underwriting commissions payable (which are held in the Trust Account as defined below), $946,169 of representative shares (see Note 7), and $604,011 of other offering costs. As described in Note 7, the $2,362,500 of deferred underwriting commissions payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement.

Upon the closing of the Initial Public Offering and Private Placement, $79,931,250 of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a trust account (the “Trust Account”) and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (c)(2), (c)(3) and (c)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

At September 30, 2022, the Company had $363,891 in cash held outside of the Trust Account. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended, or the Investment Company Act.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

The Company will provide holders of its Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially approximately $10.15 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7).

The Company will have until 12 months from the closing of the Initial Public Offering to consummate an initial Business Combination. However, if the Company anticipates that it may not be able to consummate the initial Business Combination within 12 months, it may extend the period of time to consummate a Business Combination by two additional 3-month periods (for a total of up to 18 months) without submitting proposed extensions to its shareholders for approval or offering its public shareholders redemption rights in connection therewith. The Company’s sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account $787,500 ($0.10 per share) on or prior to the date of the applicable deadline for each additional three month period. Any such payments would be made in the form of a loan, non-interest bearing and payable upon the consummation of the initial Business Combination.

Goingconcern and management’s plan (As restated)

As of September 30, 2022, the Company has a cash balance of $363,891 and a working capital deficit of $(218,124), excluding the cash currently held in the Trust Account and the deferred compensation payable upon consummation of a Business Combination. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the issuance date of the financial statements. Prior to consummation of a Business Combination, the Company has the ability to secure additional funding from the Sponsor or other related parties. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within 12 months (or 18 months, as applicable) (the “Combination Period”). The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

In connection with the preparation of the Company’s proxy statement/prospectus included in the Form F-4 registration statement with respect to the Company’s proposed business combination with E.E.W. Eco Energy World PLC, a company formed under the laws of England and Wales (“EEW”), Management identified errors made in its financial statements with respect to its recording and accrual of certain expenses in the proper period. In the third quarter of 2022, the Company incurred legal expenses with two vendors related to the Business Combination Agreement. The service was delivered throughout the third quarter of 2022, but the fees were not properly recorded in accordance with U.S. Generally Accepted Accounting Principles. This restatement note presents the changes from the previously reported balances to the adjusted balances as of and for the three and nine months ended September 30, 2022. These errors resulted in an adjustment to the net income.

The impact of the restatement on the Company’s financial statements is reflected in the following table.

Balance Sheet as of September 30, 2022	As Previously Reported		****	Adjustment		****	As Restated		****
Accrued liabilities	$	265,545		$	328,123		$	593,668
Current liabilities	$	2,808,045		$	328,123		$	3,136,168
Total liabilities	$	2,808,045		$	328,123		$	3,136,168
Accumulated deficit	$	(2,252,710	)	$	(328,123	)	$	(2,580,833	)
Total shareholders’ deficit	$	(2,252,501	)	$	(328,123	)	$	(2,580,624	)

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Statement of Operation for the three months ended September 30, 2022	As Previously<br> Reported			Adjustment			As Restated
Formation and operating costs	$	433,391		$	328,123		$	761,514
Net loss	$	(79,795	)	$	(328,123	)	$	(407,918	)
Redeemable ordinary shares, basic and diluted	$	—		$	(0.03	)	$	(0.03	)
Non-redeemable ordinary shares, basic and diluted	$	(0.04	)	$	(0.04	)	$	(0.08	)
Statement of Operation for the nine months ended September 30, 2022	As Previously<br> Reported			Adjustment			As Restated
---	---	---	---	---	---	---	---	---	---
Formation and operating costs	$	706,260		$	328,123		$	1,034,383
Net loss	$	(265,934	)	$	(328,123	)	$	(594,057	)
Redeemable ordinary shares, basic and diluted	$	0.90		$	(0.05	)		0.85
Non-redeemable ordinary shares, basic and diluted	$	(2.11	)	$	(0.05	)	$	(2.16	)
Statement of Stockholders’ Deficit for the three months ended<br>September 30, 2022	As Previously<br> Reported			Adjustment			As Restated
---	---	---	---	---	---	---	---	---	---
Net loss	$	(79,795	)	$	(328,123	)	$	(407,918	)
Accumulated deficit	$	(2,252,710	)	$	(328,123	)	$	(2,580,833	)
Total shareholders’ deficit	$	(2,252,501	)	$	(328,123	)	$	(2,580,624	)
Statement of Cash Flows for the nine months ended September 30, 2022	As Previously<br> Reported			Adjustment			As Restated
---	---	---	---	---	---	---	---	---	---
Net loss	$	(265,934	)	$	(328,123	)	$	(594,057	)
Accrued liabilities	$	265,545		$	328,123		$	593,668

NOTE

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basisof presentation

The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).

The accompanying unaudited financial statements as of September 30, 2022, and for the three and nine months ended September 30, 2022 have been prepared in accordance with U.S. GAAP for interim financial information and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the period ending December 31, 2022, or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on May 6, 2022 and April 29, 2022, respectively.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Cashand cash equivalents

The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. As of September 30, 2022 and December 31, 2021, the Company had a cash balance of $363,891 and $0 in its working capital account, respectively, and no cash equivalents.

Investmentin Trust Account

Upon the closing of the Initial Public Offering and Private Placement, $79,931,250 was placed into the Trust Account with J.P. Morgan Asset Management.

The funds held in the trust account can be invested in United States government treasury bills, notes or bonds having a maturity of 180 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier of the consummation of its first business combination and the Company’s failure to consummate a business combination within 12 months (or 18 months as applicable) from the consummation of the Initial Public Offering.

The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in investment income on trust account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. (see Note 9).

At September 30, 2022, the Company had $80,371,576 held in the Trust Account, including $353,596 and $440,326 dividends earned on investments held in Trust Account in the three and nine months ended September 30, 2022.

Emerginggrowth company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.

Useof estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Deferredoffering costs

The Company complies with the requirements of the Financial Accounting Standard Board (the “FASB”) Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offerings.” Offering costs, consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering, were charged to shareholders’ equity upon the completion of the Initial Public Offering. As of December 31, 2021, deferred offering costs amounted to $83,343 and consisted of legal, accounting, and underwriting fees. Upon consummation of the Initial Public Offering on May 2, 2022, total offering costs related to the Initial Public Offering were $5,093,930, and was allocated between the Public Shares, public warrants and public rights based on their relative fair values at the date of issuance. Accordingly, $4,647,702 was allocated to the Public Shares and charged to temporary equity (see Note 4).

Ordinaryshares subject to possible redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Accordingly, ordinary shares subject to possible redemption are presented at redemption value (plus any interest earned and/or dividends on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

Incometaxes

The Company complies with the accounting and reporting requirements of Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Netloss per share

The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. At September 30, 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.

The net income (loss) per share presented in the condensed statement of operations is based on the following:

	Three months ended<br> September 30, <br> 2022			Nine months ended<br> September 30, <br> 2022
Net loss (as restated)	$	(407,918	)	$	(594,057	)
Accretion of temporary equity to redemption value		—			(12,727,453	)
Net loss including accretion of temporary equity to redemption value (as restated)	$	(407,918	)	$	(13,321,510	)
Less: Investment income on trust account to be allocated to redeemable shares		353,596			440,326
Net loss excluding investment income on trust account (as restated)	$	(761,514	)	$	(13,761,836	)
	Three months ended September 30, 2022
---	---	---	---	---	---	---
	Redeemable <br> shares			Non-redeemable <br> shares
Basic and diluted net income/(loss) per share:
Numerators:
Allocation of net loss including accretion of temporary equity and excluding investment income on trust account	$	(601,987	)	$	(159,527	)
Investment income on trust account		353,596
Allocation of net income/(loss)	$	(248,391	)	$	(159,527	)
Denominators:
Weighted-average shares outstanding		7,875,000			2,086,875
Basic and diluted net income/(loss) per share	$	(0.03	)	$	(0.08	)

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

	Nine months ended September 30, 2022
	Redeemable <br> shares			Non-redeemable <br> shares
Basic and diluted net income/(loss) per share:
Numerators:
Allocation of net loss including accretion of temporary equity and excluding investment income on trust account	$	(9,461,321	)	$	(4,300,515	)
Investment income on trust account		440,326
Accretion of temporary equity to redemption value		12,727,453
Allocation of net income/(loss)	$	3,706,458		$	(4,300,515	)
Denominators:
Weighted-average shares outstanding		4,384,615			1,992,967
Basic and diluted net income/(loss) per share	$	0.85		$	(2.16	)

Fairvalue of financial instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 825, “Financial Instruments” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted<br>prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;<br>and
●	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,<br>such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Recentaccounting pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s financial statements.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

NOTE

INITIAL PUBLIC OFFERING

On May 2, 2022, the Company consummated its Initial Public Offering of 7,875,000 Units, including 375,000 Units that were issued pursuant to the underwriters’ partial exercise of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $78,750,000.

Each unit consists of one Class A ordinary share, one-half of one redeemable warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share for $11.50 per share, subject to certain adjustment. Each right entitles the holder to receive one-tenth of one ordinary share upon consummation of the Company’s initial Business Combination (see Note 8).

All of the 7,875,000 public shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

As of September 30, 2022, the ordinary shares reflected on the balance sheet are reconciled in the following table.

	As of <br> September 30, <br> 2022
Gross proceeds	$	78,750,000
Less:
Proceeds allocated to public warrants and public rights		(6,898,500	)
Offering costs of public shares		(4,647,702	)
Plus:
Accretion of carrying value to redemption value		13,167,778
Ordinary shares subject to possible redemption	$	80,371,576

NOTE

PRIVATE PLACEMENT

On May 2, 2022, the Company sold 3,762,500 Private Placement Warrants, including 112,500 Private Placement Warrants that were issued pursuant to the underwriters’ partial exercise of the over-allotment option, at $1.00 per warrant, generating gross proceeds of $3,762,500 in the Private Placement. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the net proceeds from the Private Placement was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.

NOTE

RELATED PARTY TRANSACTIONS

Foundershares

On December 30, 2021, the Company issued 2,156,250 of its Class B ordinary shares to the Sponsor (the “Founder Shares”) for $25,000 at a par value of $0.0001, which included an aggregate of up to 281,250 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 7). The Sponsor had paid $25,000 in exchange for the shares through a related party before December 31, 2021.

Since the underwriters partially exercised the over-allotment option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to further exercise the option (see Note 7), a total of 93,750 of the Founder Shares were no longer subject to forfeiture on May 2, 2022, and 187,500 of the Founder Shares were forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Promissorynote

The member of the Sponsor has agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering (the “Note”). The Note is non-interest bearing, unsecured and was due on the closing of the Initial Public Offering. As of September 30, 2022 and December 31, 2021, the Company has not borrowed any funds under the Note. The Note expired on May 2, 2022 and will not be extended or renewed.

Loanwith related party

The Company has agreed to borrow up to $500,000 from Eternal B.V., an affiliate of the Company through common ownership, to be used for the payment of costs related to the Initial Public Offering (the “Loan”). Pursuant to the loan agreement and its subsequent amendments, the Note is non-interest bearing, unsecured and was due on the closing of the Initial Public Offering. As of December 31, 2021, the outstanding balance of loan payable to the affiliate was $63,073, and no interest was accrued. The Loan expired on May 2, 2022 and was fully repaid to the affiliate on June 2, 2022.

On September 21, 2022, the Company entered into a loan agreement with Eternal B.V. (the “Lender”) in the principal amount of up to $180,000, on an unsecured basis and bearing no interest (the “Eternal B.V. Loan”). The Eternal BV Loan is available to be drawn down from September 21, 2022 to March 31, 2023 and its maturity date is March 31, 2024. The Lender is controlled by Charles Ratelband V, the Company’s Executive Chairman of the board of directors (the “Board”). As of September 30, 2022, the outstanding balance of the loan payable to affiliate was $180,000 and no interest was accrued.

AdministrativeService Fee

The Company entered into an administrative services agreement (the “Administrative Services Agreement”) with the Sponsor on April 27, 2022 whereby the Sponsor will perform certain services for the Company for a monthly fee of $10,000. On May 2, 2022, the Sponsor entered into an assignment agreement with Gluon Group, an affiliate of the Company, to provide the services detailed in the Administrative Service Agreement. An officer of the Company owns 505 shares of Gluon Group and serves as managing partner. As of September 30, 2022, $23,386 has been paid to Gluon Group for such services and an additional $25,394 has been accrued.

AdvisoryServices

On September 21, 2022, the Company entered into an agreement (the “Letter Agreement”) with Gluon Partners LLP (“Gluon”) to pay a fee (the “Transaction Success Fee”) upon completion of one or more successful transactions. The Company will pay Gluon $500,000 upon completion of one or more transactions with an aggregate purchase price of less than $400,000,000; and, an additional $500,000 upon completion of one or more transactions with an aggregate purchase price of more than $400,000,000. This means the total remuneration for transactions with a purchase price more than $400,000,001 would be $1,000,000. The transactions purchase price will correspond to the price paid to the sellers of the applicable target, including cash, debt, and equity funded payments. Each Transaction Success Fee will be payable upon consummation of the applicable transaction, regardless of (i) the calendar for the payment of the purchase price, (ii) how the purchase price is funded, (iii) any deferred payment subsequent to consummation of the transaction, or (iv) any adjustments to the price of the transaction subsequent to consummation. Following payment of Transaction Success Fee, any accrued fees payable to the Gluon Group by the Company will be waived.

On October 5, 2022, the Company and Gluon agreed to lower the Transaction Success Fee to a total payment of $250,000 upon successful consummation of a transaction independent of aggregate transaction price.

In addition, the Letter Agreement was amended to entitle Gluon, with respect to any financing undertaken by the Company introduced by Gluon during the term of the Letter Agreement, to the following fees: (i) for a financing involving an issuance of the Company’s senior, subordinated and/or mezzanine debt securities, a cash fee payable at any closing equal to two percent (2.0%) of the gross proceeds received by the Company at such closing; (ii) for a financing involving equity, equity-linked or convertible securities, a cash fee payable at each closing equal to five percent (5.0%) of the gross proceeds received by the Company at such closing.

In addition to the Transaction Success Fee, the Company agreed to pay Gluon Group for any reasonable and documented out-of-pocket expenses incurred in connection with providing the services for the transactions.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

NOTE

COMMITMENTS AND CONTINGENCIES

Registrationrights

The holders of the Founder Shares and warrants are entitled to registration rights pursuant to a registration rights agreement signed on April 27, 2022. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwritingagreement

On October 21, 2021, the Company engaged Maxim as its underwriter. The Company granted the underwriters a 45-day option until June 11, 2022 to purchase up to 1,125,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On May 2, 2022, the underwriters partially exercised this option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to further exercise the option on May 5, 2022.

The underwriters were entitled to an underwriting discount of $0.45 per unit, or $3,543,750 in the aggregate, of which $0.15 per unit, or $1,181,250 was paid upon the closing of the Initial Public Offering. Of the $0.45 discount, the underwriters were entitled to a deferred underwriting commission of $0.30 per unit, or $2,362,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

In addition to the underwriting discount, the Company has agreed to pay or reimburse the underwriters for travel, lodging and other “road show” expenses, expenses of the underwriters’ legal counsel and certain diligence and other fees, including the preparation, binding and delivery of bound volumes in form and style reasonably satisfactory to the representative, transaction Lucite cubes or similar commemorative items in a style as reasonably requested by the representative, and reimbursement for background checks on our directors, director nominees and executive officers, which such fees and expenses are capped at an aggregate of $125,000 (less amounts previously paid). The $125,000 was paid out of the proceeds of the Initial Public Offering on May 2, 2022.

Representativeshares

The Company has issued to Maxim and/or its designees, 118,125 shares of Class A ordinary shares upon the consummation of the Initial Public Offering (the “Representative Shares”). The Company accounted for the Representative Shares as an offering cost associated with the Initial Public Offering, with a corresponding credit to shareholder’s equity. The Company estimated the fair value of Representative Shares to be $946,181. Maxim has agreed not to transfer, assign, or sell any such shares until the completion of the Business Combination. In addition, Maxim has agreed: (i) to waive its redemption rights with respect to such shares in connection with the completion of the Business Combination; and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its Business Combination within 12 months (or 18 months, as applicable) from the closing of the Initial Public Offering.

The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the registration statement of which this prospectus forms a part pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following April 27, 2022, nor may they be sold, transferred, assigned, pledged, or hypothecated for a period of 180 days immediately following April 27, 2022 except to any underwriter and selected dealer participating in the offering and their bona fide officers or partners.

Subject to certain conditions, the Company granted Maxim, for a period beginning on May 2, 2022 and ending 12 months after the date of the consummation of the Business Combination, a right of first refusal to act as book-running managing underwriter or placement agent for any and all future public and private equity, equity-linked, convertible and debt offerings for the Company or any of its successors or subsidiaries. In accordance with FINRA Rule 5110(g)(6), such right of first refusal shall not have a duration of more than three years from April 27, 2022.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

TransactionExpenses

On August 17, 2022, the Company entered into an agreement (the “Maxim Agreement”) with Maxim to pay a fee (the “Success Fee”) for certain financial advisory services upon completion of a potential business combination with one or more one or more target companies (the “Transaction”). On October 3, 2022, the Company amended its agreement with Maxim (the “Amendment”). As amended, the Maxim Agreement provides that the Company shall pay to Maxim, upon Closing of such Transaction(s), a fee based upon the amount of cash the Company has in Trust immediately prior to consummation of the Transaction and/or contributed to the Transaction. If the amount of such cash is less than $50,000,000, Maxim’s fee shall be equal to $200,000 in cash and an additional $150,000 of common stock of the post-Transaction Company (the “Common Stock”). If the amount of such cash is equal to or greater than $40 million, the success shall be $500,000 cash. If the amount of such cash is equal to or greater than $75 million, the Success Fee shall be $500,000 cash plus an additional $500,000 payable in either cash or Common Stock, at the option of the Company. The Common Stock shall be issued to Maxim Partners LLC, shall be valued at the same price per share/exchange ratio as in the definitive Transaction documentation, and it shall have unlimited piggyback registration rights. The Success Fee shall be paid upon the consummation of the Transaction.

On July 11, 2022, the Company entered into an advisory services agreement (the “Alantra Agreement”) with ALANTRA and U.N. SDG Support Holdings LLC (“Sponsor Entity”). On October 3, 2022, the Company amended its agreement with ALANTRA. As amended, the Alantra Agreement provides that the Company will pay ALANTRA, for certain M&A advisory services, a retainer of $15,000 at signing of the engagement letter and $20,000 per month that is due and payable on the last day of each month for a maximum period of five months. Should the aggregated Transaction value be above $400,000,000, the retainer fee will increase up to $40,000 per month with the same maximum five-month period for the payment of any retainer fee.

The Company also agreed to pay certain transaction fees (“Transaction Success Fee”) as follows, if a Transaction which is introduced by ALANTRA or by another institution to which no fees are due by the Company (e.g. an institution acting on behalf of a Target) is completed, the following remuneration will be due to ALANTRA as a remuneration for its services:

●	$1,600,000 payable by the Company
●	$1,600,000 payable by or on behalf of the Sponsor Entity

If a transaction is Completed in North America, Asia, or Africa which is not introduced by ALANTRA and such Transaction requires an introductory, coadvisory, or similar fee due by the Company, the Company shall pay ALANTRA a Transaction Success Fee in the form of:

●	For the first $300,000,000 of aggregated value of the Transaction, 0.85% of each Transaction purchase price
●	For the aggregated value of the Transaction above the first $300,000,000, 0.4% of each Transaction purchase price

Notwithstanding the above, it is agreed that if a Transaction is completed, the Transaction Success Fee will be subject to a minimum of EUR 1,000,000.

Each Transaction Success Fee shall be payable upon consummation of the applicable Transaction (i.e. when the transaction is closed, following fulfillment, if applicable, of conditions precedent) regardless of (i) the calendar for the payment of the price, (ii) how the purchase price is funded, (iii) and any deferred payment subsequent to consummation of the Transaction, or (iv) any adjustment to the price of the Transaction subsequent to consummation (“Completion”).

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

NOTE

SHAREHOLDER’S EQUITY

ClassA Ordinary Shares — The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 118,125 and zero Class A shares issued and outstanding, respectively.

ClassB Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class B ordinary shares are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 1,968,750 and 2,156,250 Class B ordinary shares outstanding, respectively. As of December 31, 2021, the Class B ordinary shares outstanding included an aggregate of up to 281,250 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7). Since the underwriters partially exercised the over-allotment option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to further exercise the option (see Note 7), a total of 93,750 of the Founder Shares were no longer subject to forfeiture on May 2, 2022, and 187,500 of the Founder Shares were forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.

PreferenceShares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were no preferred shares outstanding.

Warrants — The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering (together, the “Warrants”), except that the Private Placement Warrants will be subject to certain restrictions on transfer and entitled to registration rights.

The Warrants may only be exercised for a whole number of shares. The Private Placement Warrants (including ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable, or salable until 30 days after the completion of our initial Business Combination. Following such period, the Private Placement Warrants (including the ordinary shares issuable upon exercise of the Private Placement Warrants) will be transferable, assignable, or salable, except that the Private Placement Warrants will not trade. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade.

The Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective by the ninetieth (90th) day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

The Company may call the Warrants for redemption, once they become exercisable :

●	in whole and not in part;
●	at a price of $0.01 per warrant;
●	upon a minimum of 30 days’ prior written notice of redemption; and
●	if, and only if, the last reported last sale price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days<br>within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption<br>to the warrant holders.

If the Company calls the Warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share capitalization, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants shares. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

If: (i) the Company issues additional ordinary shares or securities convertible into or exercisable or exchangeable for shares of ordinary shares for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary shares, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by such holder or affiliates, as applicable, prior to such issuance) (the “New Issuance Price”); (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation thereof (net of redemptions); and (iii) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the New Issuance Price and the Redemption Trigger Price ($18.00) shall be adjusted to equal to 180% of the greater of the Market Value and the Newly Issued Price.

The Company accounts for the Public Warrants and the Private Placement Warrants as equity instruments, so long as the Company continues to meet the accounting requirements for equity instruments.

Rights— Each holder of a right included in the unit (the “Right”) will automatically receive one-tenth (1/10) of one share of ordinary shares upon consummation of a Business Combination, except in cases where we are not the surviving company in a business combination, and even if the holder of such Right redeemed all shares of ordinary shares held by it in connection with a Business Combination. No additional consideration will be required to be paid by a holder of a Right in order to receive its additional shares upon consummation of a Business Combination, as the consideration related thereto has been included in the unit purchase price paid for by investors in the Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of Rights to receive the same per share consideration the holders of shares of ordinary shares will receive in the transaction on an as-exchanged for ordinary shares basis, and each holder of a Right will be required to affirmatively exchange its Rights in order to receive the 1/10 share underlying each Right (without paying any additional consideration) upon consummation of a Business Combination. More specifically, the Rights holder will be required to indicate its election to exchange the Right for the underlying shares within a fixed period of time after which period the Rights will expire worthless.

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

Pursuant to the Rights agreement, a Rights holder may exchange Rights only for a whole number of shares of ordinary shares. This means that the Company will not issue fractional shares in connection with an exchange of Rights and Rights may be exchanged only in multiples of 10 Rights (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like). Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Delaware General Corporation Law.

If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any such funds with respect to their Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the Rights. Accordingly, the Rights may expire worthless.

NOTE

FAIR VALUE MEASUREMENTS

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level		September 30, <br><br>2022
Assets:
Investments held in Trust Account		1	$	80,371,576

Except for the foregoing, the Company does not have any assets measured at fair value on a recurring basis at September 30, 2022.

NOTE

SUBSEQUENT EVENTS

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2022, up through the date the Company issued the financial statements.

On October 6, 2022, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with ClimateRock Holdings Limited, a Cayman Islands exempted company (“Pubco”), ClimateRock Merger Sub Limited, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), and EEW.

The total consideration to be offered by Pubco to the holders of EEW securities (each, a “Seller”) shall be a number of ordinary shares of Pubco (the “Pubco Ordinary Shares”) with an aggregate value equal to Six Hundred Fifty Million U.S. Dollars ($650,000,000), with each Pubco Ordinary Share valued at an amount equal to the price at which each ClimateRock ordinary share is redeemed or converted pursuant to the redemption of ClimateRock’s ordinary shares pursuant to ClimateRock’s organizational documents (the “Redemption Price”). For a more detailed description of the Business Combination Agreement and the transactions contemplated therein, see the Company’s Current Report on Form 8-K filed with the SEC on October 13, 2022 (the “Form 8-K”).

CLIMATEROCK

NOTES TO THE FINANCIALSTATEMENTS (UNAUDITED)

On October 3, 2022 the Company amended the Maxim Agreement and the Alantra Agreement. The Company entered into that certain first amendment (the “Amendment”), pursuant to which, the Letter Agreement was amended to decrease the Success fee, which is determined by aggregate Transaction value, as well as, location of Transaction is Completed. See Note 7 for a discussion of the Maxim Agreement and Alantra Agreement and respective amendments thereto.

On October 5, 2022, the Company amended its Letter Agreement with Gluon for certain consulting services previously disclosed in the 8-K filed September 27, 2022. The Company and Gluon entered into that certain First Amendment to the Letter Agreement (“First Amendment”), pursuant to which, the Letter Agreement was amended to decrease the Transaction Success Fee from up to $1,000,000 to $250,000. In addition, the Letter Agreement was amended to entitle Gluon, with respect to any financing undertaken by the Company introduced by Gluon during the term of the Letter Agreement, to the following fees: (i) for a financing involving an issuance of the Company’s senior, subordinated and/or mezzanine debt securities, a cash fee payable at any closing equal to two percent (2.0%) of the gross proceeds received by the Company at such closing; (ii) for a financing involving equity, equity-linked or convertible securities, a cash fee payable at each closing equal to five percent (5.0%) of the gross proceeds received by the Company at such closing.

On November 12, 2022, the Company entered into a loan agreement with the Lender in the principal amount of up to $300,000, on an unsecured basis and bearing no interest (the “Eternal B.V. Loan”). The Eternal B.V. Loan is available to be drawn down from November 12, 2022 to March 31, 2024, and its maturity date is March 31, 2024.

ITEM

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to ClimateRock. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to U.N. SDG Support LLC The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

CautionaryNote Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. Such forward-looking statements are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

The following discussion and analysis of our financial condition and results of operations has been amended and restated to give effect to the restatement, as described in Note 2, of our unaudited interim financial statements and should be read in conjunction with the unaudited financial statements and the notes thereto included in this Quarterly Report under “Item 1 Financial Statements”. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

The Company is a Cayman Islands exempted company incorporated as a blank check company on December 6, 2021. The Company was formed for the purpose of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar Business Combination.

Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on opportunities in environmental protection, renewable energy, fighting climate change, and any other related industries. ClimateRock will target companies with established operating models that have strong management teams, realigned capital structures, positive cash flows prospects, and a clear and well-defined pathway for growing profitably over the long-term. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2022, the Company had not yet commenced any operations. All activity through September 30, 2022 relates to the Company’s formation and the Initial Public Offering, which is described below, and post-offering activities in search for a target to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate nonoperating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The Company commenced operations after obtaining adequate financial resources through (i) the Initial Public Offering of 7,875,000 Units at $10.00 per Unit (which includes 375,000 units in connection with the underwriter’s partial exercise of the over-allotment option) and (ii) the sale of 3,762,500 Private Placement Warrants with an exercise price of $11.50 per warrant at a price of $1.00 per Private Placement Warrant to the Company’s Sponsor.

The Units were listed on the Nasdaq Global Market (“Nasdaq”). The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940 as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

Upon the closing of the Initial Public Offering, $10.15 per Unit sold in the Initial Public Offering was placed in the Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

The Sponsor, officers, directors and advisors (the “Initial Shareholders”) have agreed (a) to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s amended and restated memorandum and articles of association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the amended and restated certificate of incorporation relating to shareholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and the Private Placement Warrants (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Initial Shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.

RecentDevelopments

The total consideration to be offered by Pubco to the holders of EEW securities (each, a “Seller”) shall be a number of Pubco Ordinary Shares with an aggregate value equal to Six Hundred Fifty Million U.S. Dollars ($650,000,000), with each Pubco Ordinary Share valued at an amount equal to the price at which each ClimateRock ordinary share is redeemed or converted pursuant to the redemption of ClimateRock’s ordinary shares pursuant to ClimateRock’s organizational documents (the “Redemption Price”).

For a more detailed description of the Business Combination Agreement and the transactions contemplated therein, see the Company’s Current Report on Form 8-K filed with the SEC on October 13, 2022 (the “Form 8-K”).

Resultsof Operations (As restated)

Our entire activity since inception up to September 30, 2022 is related to our formation, the Initial Public Offering, and we will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest. We will generate nonoperating income in the form of interest income from the proceeds derived from the Initial Public Offering. Following the closing of our Initial Public Offering on May 2, 2022, we expect to incur increased expenses as a result of becoming a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2022, the Company reported a net loss of $407,918, which consists of general and administrative expenses, offset by $353,596 of investment income earned in the Trust Account.

For the nine months ended September 30, 2022, the Company reported a net loss of $594,057, which consists of general and administrative expenses, offset by $440,326 of investment income earned in the Trust Account.

Liquidityand Capital Reserves (As restated)

On May 2, 2022, we consummated our Initial Public Offering of 7,875,000 Units, including 375,000 Units that were issued pursuant to the underwriters’ partial exercise of their over-allotment option. Simultaneously, the Company sold 3,762,500 Private Placement Warrants, including 112,500 Private Placement Warrants that were issued pursuant to the underwriters’ partial exercise of the over-allotment option. From the proceeds of the Initial Public Offering and Private Placement Warrants, the Company retained approximately $1,100,000 for working capital needs after transfer of proceeds to the Trust Account and payment of expenses related to the Initial Public Offering and directors and officers insurance.

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). On September 21, 2022, we entered into a loan agreement with Eternal B.V. (the “Lender”) in the principal amount of up to $180,000, on an unsecured basis and bearing no interest (the “Eternal B.V. Loan”). The Eternal BV Loan is available to be drawn down from September 21, 2022 to March 31, 2023 and its maturity date is March 31, 2024. Additionally, on November 12, 2022, we entered into a loan agreement with the Lender in the principal amount of up to $300,000, on an unsecured basis and bearing no interest (the “Eternal B.V. Loan”). The Eternal B.V. Loan is available to be drawn down from November 12, 2022 to March 31, 2024, and its maturity date is March 31, 2024. The Lender is controlled by Charles Ratelband V, the Company’s Executive Chairman of the board of directors (the “Board”). As of September 30, 2022, the outstanding balance of the loan payable to affiliate was $180,000 and no interest was accrued.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Off-BalanceSheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022.

ContractualObligations

RegistrationRights

Pursuant to a registration rights agreement entered into on April 27, 2022, the holders of the Founder Shares (as defined below) and the Private Placement Warrants (and their underlying securities) are entitled to registration rights. The Company will bear the expenses incurred in connection with the filing of any registration statements pursuant to such registration rights.

UnderwritingAgreement

Pursuant to the underwriting agreement, the underwriters received a cash underwriting discount of $1,181,250 following the consummation of the Initial Public Offering. The underwriters are also entitled to a deferred commission of $2,362,500, which will be payable solely in the event that the Company completes a Business Combination. In addition, the underwriters also received 118,125 Units in the Initial Public Offering, with such Units restricted from sale until the closing of the Business Combination and with no redemption rights from the Trust Account.

Additionally, the Company granted the underwriters for a period beginning on the closing of the Initial Public Offering and ending on the earlier of the 12 month anniversary of the closing of a Business Combination or April 27, 2025, a right of first refusal to act as (i) exclusive financial advisor in connection with all of the Company’s proposed business combinations for a fee of up to 6.0% of the proceeds of the Initial Public Offering (subject to the Company’s right to allocate up to 50% of such fee to another financial institution or extinguish such amount in Company’s sole discretion), and (ii) sole investment banker, sole book-runner and/or sole placement agent, at underwriters’ sole discretion, for each and every future public and private equity and debt Initial Public Offering, including all equity linked financings, during such period for the Company or any successor to it or any of its subsidiaries, on terms agreed to by both the Company and underwriters in good faith.

TransactionExpenses

On August 17, 2022, we entered into an agreement (the “Maxim Agreement”) with Maxim to pay a fee (the “Success Fee”) for certain financial advisory services upon completion of one or more successful transactions. On October 3, 2022, the Company amended its agreement with Maxim (the “Amendment”). As amended, the Maxim Agreement provides that we shall pay to Maxim, upon Closing of such Transaction(s), a fee based upon the amount of cash the Company has in Trust immediately prior to consummation of the Transaction and/or contributed to the Transaction. If the amount of such cash is less than $50,000,000, Maxim’s fee shall be equal to $200,000 in cash and an additional $150,000 of common stock of the post-Transaction Company (the “Common Stock”). If the amount of such cash is equal to or greater than $40 million, the success shall be $500,000 cash. If the amount of such cash is equal to or greater than $75 million, the Success Fee shall be $500,000 cash plus an additional $500,000 payable in either cash or Common Stock, at the option of the Company. The Common Stock shall be issued to Maxim Partners LLC, shall be valued at the same price per share/exchange ratio as in the definitive Transaction documentation, and it shall have unlimited piggyback registration rights. The Success Fee shall be paid upon the consummation of the Transaction.

On July 11, 2022, we entered into an advisory services agreement (the “Alantra Agreement”) with ALANTRA and Sponsor Entity. On October 3, 2022, the Company amended its agreement with ALANTRA. We will pay ALANTRA, for certain M&A advisory services, a retainer of $15,000 at signing of the engagement letter and $20,000 per month that is due and payable on the last day of each month for a maximum period of five months. Should the aggregated Transaction value be above $400,000,000, the retainer fee will increase up to $40,000 per month wit the same maximum five-month period for the payment of any retainer fee.

We also agreed to pay certain transaction fees (“Transaction Success Fee”) as follows, if a Transaction which is introduced by ALANTRA or by another institution to which no fees are due by the Company (e.g. an institution acting on behalf of a Target) is Completed the following remuneration will be due to ALANTRA as a remuneration for its services:

●	$1,600,000 payable by the Company
●	$1,600,000 payable by or on behalf of the Sponsor Entity

If a transaction is completed in North America, Asia, or Africa which is not introduced by ALANTRA and such Transaction requires an introductory, coadvisory, or similar fee due by us, we shall pay ALANTRA a Transaction Success Fee in the form of:

●	For the first $300,000,000 of aggregated value of the Transaction, 0.85% of each Transaction purchase price
●	For the aggregated value of the Transaction above the first $300,000,000, 0.4% of each Transaction purchase price

Notwithstanding the above, it is agreed that if a Transaction is completed, the Transaction Success Fee will be subject to a minimum of EUR 1,000,000.

RelatedParty Transactions

FounderShares

During the period ended December 31, 2021, we issued an aggregate of 2,156,250 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000 in cash. The Founder Shares included an aggregate of up to 281,250 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Initial Shareholders will collectively own 20% of our issued and outstanding shares after the Initial Public Offering (assuming the Initial Shareholders do not purchase any Public Shares in the Initial Public Offering and excluding the securities underlying the Private Placement Warrants).

On May 2, 2022, the underwriters partially exercised the over-allotment option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to further exercise the option on May 5, 2022. Accordingly, a total of 93,750 of the Founder Shares are no longer subject to forfeiture on May 2, 2022, and 187,500 of the Founder Shares were forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.

The Initial Shareholders have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until the earlier of (i) six months after the date of the consummation of the Company’s initial Business Combination or (ii) the date on which we consummate a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our initial shareholders with respect to any Founder Shares.

PromissoryNote

Loanwith Related Party

Additionally, on November 12, 2022, the Company entered into a loan agreement with the Lender in the principal amount of up to $300,000, on an unsecured basis and bearing no interest (the “Eternal B.V. Loan”). The Eternal B.V. Loan is available to be drawn down from November 12, 2022 to March 31, 2024, and its maturity date is March 31, 2024.

AdministrativeService Fee

AdvisoryServices

On September 21, 2022, the Company entered into the Letter Agreement with Gluon to pay a Transaction Success Fee upon completion of one or more successful transactions. The Company will pay Gluon $500,000 upon completion of one or more transactions with an aggregate purchase price of less than $400,000,000; and, an additional $500,000 upon completion of one or more transactions with an aggregate purchase price of more than $400,000,000. This means the total remuneration for transactions with a purchase price more than $400,000,001 would be $1,000,000. The transactions purchase price will correspond to the price paid to the sellers of the applicable target, including cash, debt, and equity funded payments. Each Transaction Success Fee will be payable upon consummation of the applicable transaction, regardless of (i) the calendar for the payment of the purchase price, (ii) how the purchase price is funded, (iii) any deferred payment subsequent to consummation of the transaction, or (iv) any adjustments to the price of the transaction subsequent to consummation. Following a payment of Transaction Success Fee, any accrued fees payable to the Gluon Group by the Company will be waived.

CriticalAccounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We had identified the following as its critical accounting policies:

Deferredoffering costs

Netloss per share

Ordinaryshares subject to possible redemption

Recentaccounting pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s financial statements.

Factorsthat may adversely affect our results of operations

Our results of operations and our ability to complete a Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete a Business Combination.

ITEM

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM

CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluationof Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) as of September 30, 2022. After filing our original third quarter Form 10-Q, and upon re-evaluation and consultation with our management team, our audit committee concluded that it was appropriate to restate our previously issued financial statements included in the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022. As part of such process, we have identified a material weakness in our internal control over financial reporting related to the Company’s recording and accruing of expenses. As a result of this material weakness, our management has concluded that our disclosure controls and procedures were not effective as of September 30, 2022. The Company’s internal control over financial reporting were not effective, due to a material weakness in our internal control related to certain errors made in the recording and accrual of certain legal expenses for such reporting period. As a result, management performed additional analysis as deemed necessary to ensure that our financial statements included in this Quarterly Report on Form 10-Q/A present fairly in all material respects our financial position, results of operations and cash flows for the period presented. Management intends to implement remediation steps to improve its disclosure controls and procedures and its internal controls over financial reporting. Specifically, the Company intends to work closely with its financial advisors to ensure balances being recorded at each period end represent the accurate amounts the Company

Changesin Internal Control Over Financial Reporting

Other than as discussed above, there have been no changes to our internal control over financial reporting during the quarter ended September 30, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART

II - OTHER INFORMATION

ITEM

LEGAL PROCEEDINGS

To the knowledge of our management team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

ITEM

1A. RISK FACTORS

As of the date of this Quarterly Report, other than as set forth below, there have been no material changes with respect to those risk factors previously disclosed in the registration statement for our Initial Public Offering and our Quarterly Report on Form 10-Q for the period ended June 30, 2022, as filed with the SEC on August 11, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

Wehave identified a material weakness in our internal control over financial reporting as of September 30, 2022. If we are unable to developand maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financialresults, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.

On November 9, 2022, we filed our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Q3 Form 10-Q”). As described in Note 2, Management identified errors in its financial statements made with respect to its recording and accrual of certain expenses. In the third quarter of 2022, the Company incurred legal expenses with two vendors related to the Business Combination Agreement. The service was delivered throughout the third quarter of 2022 but the fees were not properly recorded in accordance with Generally Accepted Accounting Principles. After filing our original third quarter Form 10-Q, and upon re-evaluation and consultation with our management team, our audit committee concluded that it was appropriate to restate our previously issued financial statements included in the Q3 Form 10-Q. As part of such process, we have identified a material weakness in our internal control over financial reporting related to the Company’s recording and accruing of expenses. As a result of this material weakness, our management has concluded that our disclosure controls and procedures were not effective as of September 30, 2022. We have taken a number of measures designed to remediate such material weaknesses, however, if we are unable to remediate our material weaknesses in a timely manner or we identify additional material weaknesses, we may be unable to provide required financial information in a timely and reliable manner and we may incorrectly report financial information. Likewise, if our financial statements are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which our securities are listed, the SEC or other regulatory authorities. The existence of material weaknesses in internal control over financial reporting could adversely affect our reputation or investor perceptions of us, which could have a negative effect on the trading price of our shares. We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. Even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

Tomitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, we may, at any time,instruct the trustee to liquidate the securities held in the Trust Account and instead to hold the funds in the Trust Account in cashitems until the earlier of the consummation of our initial Business Combination or our liquidation. As a result, following the liquidationof securities in the Trust Account, we would likely receive minimal interest, if any, on the funds held in the Trust Account, which wouldreduce the dollar amount our public shareholders would receive upon any redemption or liquidation of the Company.

The funds in the Trust Account have, since our Initial Public Offering, been held only in U.S. government treasury obligations with a maturity of 180 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act, we may, at any time, instruct Continental Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account as cash items until the earlier of the consummation of our initial Business Combination or the liquidation of the Company. Following such liquidation, we would likely receive minimal interest, if any, on the funds held in the Trust Account. However, interest previously earned on the funds held in the Trust Account still may be released to us to pay our taxes, if any, and certain other expenses as permitted. As a result, any decision to liquidate the securities held in the Trust Account and thereafter to hold all funds in the Trust Account in cash items would reduce the dollar amount our public shareholders would receive upon any redemption or liquidation of the Company.

In the event that we may be deemed to be an investment company, we may be required to liquidate the Company.

Wemay not be able to complete an initial Business Combination with certain potential target companies if a proposed transaction with thetarget company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.

Certain acquisitions or Business Combinations may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations. In the event that such regulatory approval or clearance is not obtained, or the review process is extended beyond the period of time that would permit an initial Business Combination to be consummated with us, we may not be able to consummate a Business Combination with such target.

Among other things, the U.S. Federal Communications Act prohibits foreign individuals, governments, and corporations from owning more than a specified percentage of the capital stock of a broadcast, common carrier, or aeronautical radio station licensee. In addition, U.S. law currently restricts foreign ownership of U.S. airlines. In the United States, certain mergers that may affect competition may require certain filings and review by the Department of Justice and the Federal Trade Commission, and investments or acquisitions that may affect national security are subject to review by the Committee on Foreign Investment in the United States (“CFIUS”). CFIUS is an interagency committee authorized to review certain transactions involving foreign investment in the United States by foreign persons in order to determine the effect of such transactions on the national security of the United States. Our Chairman, Charles Ratelband V, a Dutch citizen, is sole managing member of our Sponsor and holds an approximate 90% interest in the Sponsor, and therefore we or our Sponsor may constitute a “foreign person” under CFIUS rules and regulations.

Outside the United States, laws or regulations may affect our ability to consummate a Business Combination with potential target companies incorporated or having business operations in jurisdiction where national security considerations, involvement in regulated industries (including telecommunications), or in businesses relating to a country’s culture or heritage may be implicated.

U.S. and foreign regulators generally have the power to deny the ability of the parties to consummate a transaction or to condition approval of a transaction on specified terms and conditions, which may not be acceptable to us or a target. In such event, we may not be able to consummate a transaction with that potential target.

As a result of these various restrictions, the pool of potential targets with which we could complete an initial Business Combination may be limited and we may be adversely affected in terms of competing with other SPACs that do not have similar ownership issues. Moreover, the process of government review could be lengthy. Because we have only a limited time to complete our initial Business Combination, our failure to obtain any required approvals within the requisite time period may require us to liquidate. If we liquidate, our public shareholders may only receive $10.15 per share, and our warrants will expire worthless. This will also cause you to lose any potential investment opportunity in a target company and the chance of realizing future gains on your investment through any price appreciation in the combined company.

Thereis substantial doubt about our ability to continue as a “going concern.”

In connection with our assessment of going concern considerations under applicable accounting standards, management has determined that our possible need for additional financing to enable us to negotiate and complete our initial Business Combination raises substantial doubt about our ability to continue as a going concern through approximately one year from the date the financial statements were issued.

Changesto laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations,interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial BusinessCombination.

We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state and local governments and applicable non-U.S. jurisdictions. In particular, we are required to comply with certain SEC and potentially other legal and regulatory requirements, and our consummation of an initial Business Combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications and any post-Business Combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, including our ability to negotiate and complete an initial Business Combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial Business Combination.

ITEM

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

For a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, as filed with the SEC on June 10, 2022. There has been no material change in the planned use of proceeds from the Company’s Initial Public Offering and Private Placement as described in the registration statement for the Initial Public Offering.

ITEM

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM

MINE SAFETY DISCLOSURES

Not applicable.

ITEM

OTHER INFORMATION

On August 17, 2022, the Company entered into an agreement (the “Maxim Agreement”) with Maxim to pay a fee (the “Success Fee”) for certain financial advisory services upon completion of one or more successful transactions. On October 3, 2022, the Company amended its agreement with Maxim (the “Amendment”). As amended, the Maxim Agreement provides that the Company shall pay to Maxim, upon Closing of such Transaction(s), a fee based upon the amount of cash the Company has in Trust immediately prior to consummation of the Transaction and/or contributed to the Transaction. If the amount of such cash is less than $50,000,000, Maxim’s fee shall be equal to $200,000 in cash and an additional $150,000 of common stock of the post-Transaction Company (the “Common Stock”). If the amount of such cash is equal to or greater than $40 million, the success shall be $500,000 cash. If the amount of such cash is equal to or greater than $75 million, the Success Fee shall be $500,000 cash plus an additional $500,000 payable in either cash or Common Stock, at the option of the Company. The Common Stock shall be issued to Maxim Partners LLC, shall be valued at the same price per share/exchange ratio as in the definitive Transaction documentation, and it shall have unlimited piggyback registration rights. The Success Fee shall be paid upon the consummation of the Transaction.

●	$1,600,000<br>payable by the Company
●	$1,600,000<br>payable by or on behalf of the Sponsor Entity
---	---

●	For<br>the first $300,000,000 of aggregated value of the Transaction, 0.85% of each Transaction purchase price
●	For<br>the aggregated value of the Transaction above the first $300,000,000, 0.4% of each Transaction purchase price
---	---

Notwithstanding the above, it is agreed that if a Transaction is completed, the Transaction Success Fee will be subject to a minimum of EUR 1,000,000.

ITEM

EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

No.	Description of Exhibit
2.1	Business Combination Agreement, dated as of October 6, 2022, by and among ClimateRock, ClimateRock Holdings Limited, ClimateRock Merger Sub Limited and E.E.W. Eco Energy World PLC. ^(1)^
10.1	Letter Agreement, dated as of September 21, 2022, by and between ClimateRock and Gluon Partners LLP. ^(1)^
10.2	Loan Agreement, dated as of September 21, 2022, by and between ClimateRock and Eternal BV. ^(1)^
10.3	First Amendment to the Letter Agreement, dated October 5, 2022, by and between ClimateRock and Gluon Partners LLP. ^(1)^
10.4	Engagement<br> Letter, dated as of August 17, 2022, by and between ClimateRock and Maxim Group LLC, as amended.*
10.5	First Amendment to the Engagement Letter, dated September 20, 2022, by and between ClimateRock and Maxim Group LLC.*
10.6	Second Amendment to the Engagement Letter, dated October 3, 2022, by and between ClimateRock and Maxim Group LLC.*
10.7	Third Amendment to the Engagement Letter, dated October 4, 2022, by and between ClimateRock and Maxim Group LLC.*
10.8	Advisory Services Agreement, dated as of July 11, 2022, by and between ClimateRock ALANTRA Corporate Finance, S.A.U. and U.N. SDG Support Holdings LLC, as amended.*
10.9	Amendment to the Advisory Services Agreement, dated as of July 11, 2022, by and between ClimateRock ALANTRA Corporate Finance, S.A.U. and U.N. SDG Support Holdings LLC, as amended.*
31.1	Certification<br> of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted<br> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2	Certification<br> of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted<br> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1	Certification<br> of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2	Certification<br> of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS	Inline<br> XBRL Instance Document.*
101.SCH	Inline<br> XBRL Taxonomy Extension Schema Document.*
101.CAL	Inline<br> XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF	Inline<br> XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB	Inline<br> XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE	Inline<br> XBRL Taxonomy Extension Presentation Linkbase Document.*
104	Cover<br> Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*
*	Filed<br> herewith.
---	---
**	Furnished<br> herewith.
(1)	Incorporated<br>by reference to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on November 9, 2022.
---	---

SIGNATURE

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:<br> December 21, 2022	CLIMATEROCK
	By:	/s/<br> Per Regnarsson
		Per<br> Regnarsson
		Chief<br> Executive Officer

Exhibit 10.4

August 17, 2022

Per Regnarsson

Chief Executive Officer

50 Sloane Avenue, London, SW3 3DD,

United Kingdom

RE: Advisory Services

Dear Mr. Regnarsson:

1. Relationship.

A. ClimateRock, collectively with its subsidiaries (the “Company”) engages Maxim Group LLC (“Maxim” and together with the Company, the “Parties”) as its advisor with respect to providing services in connection with one or several Transactions (as defined in Section 1(D) herein) involving one or several entities and/or assets identified by the Company (or any agent of the Company other than Maxim) (the “Target”). It is understood and agreed that the Company’s engagement of Maxim pursuant to this agreement (the “Agreement”) is on a non-exclusive basis.

During the Term (as defined below), if requested by the Company, Maxim shall provide the following services (collectively referred to herein as the “AdvisoryServices”) in connection with a potential Transaction(s):

(i)	analyze and assist the Company with respect to the successful execution<br>of PIPE and/or other financing alternatives;
(ii)	provide the Company with advice regarding communications with and marketing<br>to investors and liaise with investors on behalf of the Company regarding potential Transactions also with a view to minimizing redemptions;
---	---
(iii)	at the Company’s request, meet with the Company’s Board of Directors<br>to discuss the proposed Transaction(s) and its/their financial implications; and
---	---
(iv)	provide such other financial advisory and investment banking services upon<br>which the Parties may mutually agree.
---	---

B. The Parties understand and agree that, during the Term, Maxim shall be required to perform only such tasks as may be reasonably requested by the Company in connection with the Advisory Services and therefore may not necessarily perform all the tasks listed above.

The Parties further understand that Maxim’s tasks may not be limited to those listed in this paragraph and that additional tasks may be included, as mutually agreed by the Parties. The Parties further understand and agree that the Company will not utilize the Advisory Services performed by Maxim for any purpose other than those stated in this Agreement, and that the existence of this Agreement and the product of Maxim’s Advisory Services are confidential and shall not in any way be communicated by the Company or Maxim to any third party(s) interested in engaging in a Transaction, except to the extent that such disclosure is required by law, including the federal securities laws, rule, regulation, the Securities and Exchange Commission (“SEC”) or any self-regulatory organization or stock exchange requirement or judicial or administrative process (the foregoing, collectively, “Legal Requirement”). The Parties further understand and agree that the Advisory Services rendered by Maxim do not include providing a fairness opinion for use in any filing with the SEC or in any proxy materials to be sent to the Company’s shareholders and that the Company shall not use any of the materials prepared by Maxim for any purpose other than internal use without the express written consent of Maxim, except to the extent such use is required by the Company to comply with its obligations under any Legal Requirement.

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 2 of 9

C. Notwithstanding anything contained herein, the Company understands and agrees that Maxim shall not provide “proxy solicitation” services to the Company and shall not be specifically recommending to shareholders of the Company the manner in which such shareholders should vote with respect to any Transaction.

D. As used in this Agreement, the term “Transaction” shall mean, the following: in each case, constituting a business combination (i) the acquisition of stock, options, warrants or other securities or rights to acquire stock (a) constituting a majority of the then outstanding common stock of a Target(s) or (b) possessing a majority of the then outstanding voting power of a Target(s); (ii) any similar purchase or other acquisition of a majority of the total equity interest in a Target(s) by the Company; (iii) a merger, acquisition, reverse takeover, reverse merger or consolidation involving the Company and a Target(s); (iv) the acquisition by the Company of any of the businesses or assets of a Target(s); (v) the formation of a joint venture or partnership between the Company and Target(s), or (vi) an acquisition of a majority of the Company by a strategic partner or other similarly situated entity. As used in this Agreement, the term (A) “Control” of a person shall mean, the possession, directly or indirectly, of the power to direct or cause the direction of the management and business of such person, whether through the ownership of voting securities, by contract or otherwise; (B) “Closing” shall mean, with respect to a Transaction, the consummation of the Transaction pursuant to a definitive written agreement with respect to the Transaction (the “Transaction Agreement”) and (C) “Representatives” with respect to any person shall mean such person’s affiliates and its and its affiliate’s respective directors, managers, officers, employees, consultants, shareholders, advisors, agents and other representatives, and in the case of the Company, Target and the Company’s actual and potential financing sources for the Transaction; provided, that for purposes of this Agreement, Maxim and the Company shall not be deemed to be Representatives of each other.

2. Termof Agreement. The term of this Agreement shall run until the consummation of a Transaction or the liquidation of the Company (such period, subject to earlier termination in accordance with this Section 2, the “Term”); provided, that the Company may terminate this Agreement for Cause by providing written notice to Maxim (a “Cause Termination”). Upon the termination or expiration of this Agreement, neither party will have any continuing liability or continuing obligation hereunder, except that (i) Maxim shall nonetheless be entitled to receive all amounts due to Maxim in consideration for services rendered hereunder by Maxim to the extent provided in Sections 3 and 4 hereof, (ii) the terms and provisions of Sections 5 through 20 (including Exhibit A hereto) shall survive the termination or expiration of this Agreement and (iii) termination or expiration of this Agreement shall not relieve a party of liability for breach of this Agreement prior to such termination or expiration. For the purposes of this Agreement, “Cause” shall mean any willful misconduct or gross negligence in the performance of the Advisory Services hereunder or a material breach of this Agreement by Maxim or its Representatives that has not been addressed or cured by Maxim within twenty (20) days after receipt by Maxim of written notice from the Company specifying in reasonable detail the facts and circumstances that it believes constitute “Cause” hereunder.

3. Fees.

A. If the Company Closes a Transaction(s) with a Target(s), during the Term, then the Company shall pay to Maxim in cash, upon Closing of such Transaction(s), a fixed fee of $1 million provided that no such fee shall be due if this Agreement is terminated for Cause in accordance with Section 2. For the sake of clarity, it is understood and agreed that Maxim shall receive its fee upon Closing of such Transaction(s) and when consideration is received by the Company.

B. The Company acknowledges and agrees that any compensation payable or paid to Maxim hereunder shall not be construed or characterized as compensation to an underwriter within the meaning of the rules of the Financial Industry Regulatory Authority, Inc. The Company hereby recognizes that the fees contemplated by this Agreement do not waive or in any way obviate the Company’s obligation to pay any of the previously agreed upon deferred compensation due and payable to Maxim under the Underwriting Agreement dated April 29, 2022, between Maxim and the Company (the “Underwriting Agreement”).

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 3 of 9

4. Expenses. Subject to Section 18 below, in addition to any fees payable hereunder, the Company shall reimburse Maxim for all reasonable and documented out-of-pocket expenses incurred by Maxim for travel (business class tickets), food, lodging and other reasonable documented out-of-pocket expenses incurred by Maxim in connection with the services performed by Maxim pursuant to this Agreement provided that any individual travel expenses in excess of $1,500 (one thousand five hundred Dollars) shall need the prior approval (including via electronic mail) of the Company and provided that expenses shall not exceed $15,000 (fifteen thousand Dollars) in the aggregate unless approved by the Company in writing or e-mail. In each case, after the submission of properly evidenced expenses to the Company, the expenses shall be reimbursed thirty (30) days from the date the Company receives the invoice.

5. Independent Contractor. The Parties agree that Maxim is acting solely as an independent contractor under this Agreement. Maxim is not authorized to make any representations, warranties, covenants or commitments of any nature whatsoever on behalf of the Company, unless it has obtained the previous authorization of the Company in writing.

6.Indemnification. The Company agrees to indemnify and hold harmless the Indemnified Parties in accordance with the terms set forth in Exhibit A of this Agreement. For the avoidance of doubt, Exhibit A and this Section 6 shall in all respects be subject to Section 18.

7. Confidentiality

A.	During the Term, the Company agrees to reasonably cooperate with Maxim and to furnish to Maxim any and<br>all information and data concerning the Company and a proposed Transaction reasonably requested by Maxim that Maxim deems reasonably necessary<br>and requests for the rendering of its services hereunder.
B.	Maxim acknowledges that, in connection with the services to be provided pursuant to this Agreement, certain<br>confidential, non-public and proprietary information concerning the Company, any Target or the Transaction and any potential investors<br>in connection therewith (“Confidential Information”) has been or may be directly or indirectly disclosed by the Company,<br>any Target or their respective Representatives to Maxim or its Representatives. Maxim agrees that, without the Company’s prior consent,<br>no Confidential Information will be (x) used by Maxim or its Representatives other than in connection with performing the services under<br>this Agreement or (y) disclosed, in whole or in part, by Maxim or its Representatives to any other person other than: (i) to those Representatives<br>of Maxim who need access to such Confidential Information for purposes of performing the services to be provided hereunder, who are informed<br>of the confidential nature of such information and bound by non-disclosure and non-use obligations consistent with the provisions of this<br>Agreement; (ii) to the Company, its Board of Directors or executive officers and each of the Company’s other Representatives bound<br>by confidentiality obligations; or (iii) as may be required by Legal Requirement.
---	---

During the Term, the Company agrees to reasonably cooperate with Maxim and to furnish to Maxim any and all information and data concerning the Company and a proposed Transaction reasonably requested by Maxim that Maxim deems reasonably necessary and requests for the rendering of its services hereunder.

Maxim acknowledges that, in connection with the services to be provided pursuant to this Agreement, certain confidential, non-public and proprietary information concerning the Company, any Target or the Transaction and any potential investors in connection therewith (“Confidential Information”) has been or may be directly or indirectly disclosed by the Company, any Target or their respective Representatives to Maxim or its Representatives. Maxim agrees that, without the Company’s prior consent, no Confidential Information will be (x) used by Maxim or its Representatives other than in connection with performing the services under this Agreement or (y) disclosed, in whole or in part, by Maxim or its Representatives to any other person other than: (i) to those Representatives of Maxim who need access to such Confidential Information for purposes of performing the services to be provided hereunder, who are informed of the confidential nature of such information and bound by non-disclosure and non-use obligations consistent with the provisions of this Agreement; (ii) to the Company, its Board of Directors or executive officers and each of the Company’s other Representatives bound by confidentiality obligations; or (iii) as may be required by Legal Requirement.

---

The term “Confidential Information” does not include any information: (a) that was already in the possession of Maxim or any of its Representatives on a non-confidential basis prior to the time of disclosure to Maxim or such Representatives; (b) obtained by Maxim or any of its Representatives from a third person which, insofar as is known to Maxim or such Representatives after reasonably inquiry, is not subject to any prohibition against disclosure; (c) which was or is independently developed by Maxim or any of its Representatives without use of or reference to any Confidential Information or violating any confidentiality obligations under this Agreement; or (d) which was or becomes generally available to the public through no fault of or breach of this Agreement by Maxim or its Representatives. If Maxim or its Representative becomes required by Legal Requirement to disclose any Confidential Information, (x) Maxim shall provide prompt notice thereof (to the extent permitted by Legal Requirement) to the Company reasonably in advance of any disclosure, (y) Maxim will (and will cause its Representatives to) reasonably cooperate (at the sole expense of the Company) with any reasonable request of the Company to seek an order or other remedy to prevent or narrow such disclosure, and (z) if after compliance with clauses (x) and (y) above, such disclosure is still required after giving effect to any successful efforts by the Company to prevent or narrow such disclosure, Maxim or its Representative, as applicable, may disclose only that Confidential Information which its counsel advises it is required by Legal Requirement to disclose.

Maxim acknowledges that U.S. securities laws and other laws prohibit any person who has material, non-public information concerning a public company from purchasing or selling any of its securities, and from communicating such information to any person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities. Maxim acknowledges that the confidentiality provisions of this Section 7B shall be deemed to be an agreement to keep the Confidential Information in confidence as contemplated by Regulation FD promulgated by the SEC. In addition, Maxim acknowledges and agrees that some of the Confidential Information may be considered “material non-public information” for purposes of the federal securities laws and that Maxim and its Representatives will abide by all securities laws relating to the handling of and acting upon material non-public information of the Company. The obligations of Maxim set forth in this Section 7B shall remain in effect during the term of this Agreement and for a period of two (2) years after the termination or expiration of this Agreement.

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 4 of 9

8. Certain Representationsand Warranties of the Company. The Company represents and warrants to Maxim that neither the execution of this Agreement nor the Company’s performance of its obligations hereunder will conflict with or result in a breach of any of the terms and provisions of, or constitute a default (or an event which with notice or the lapse of time, or both, would constitute a default) under, or result in the creation or imposition of any lien, or encumbrance upon any property or assets of the Company, pursuant to any oral or written agreement, understanding or arrangement to which the Company or its subsidiaries is a party. In addition, the Company represents and warrants:

A.	Maxim will be afforded full access to all due diligence in connection with any Transaction hereunder;<br>and
B.	The Company will obtain a fairness opinion from a third-party FINRA member broker-dealer with respect<br>to any Transaction hereunder.
---	---

9. Choice of Law; Venue; Attorney’sFees; Waiver of Jury Trial.

This Agreement shall be enforced, governed by and construed in accordance with the laws of New York without regard to principles of conflict of laws. Any controversy between the Parties shall be resolved by arbitration before the American Arbitration Association (“AAA”) in New York City. The foregoing arbitration agreement should be read in conjunction with these disclosures:

(a)	ARBITRATION IS FINAL AND BINDING ON THE PARTIES;
(b)	THE PARTIES ARE WAIVING THEIR RIGHT TO SEEK REMEDIES IN COURT, INCLUDING THE RIGHT TO JURY TRIAL;
---	---
(c)	PRE-ARBITRATION DISCOVERY IS GENERALLY MORE LIMITED THAN AND DIFFERENT FROM COURT PROCEEDING; AND
---	---
(d)	THE ARBITRATORS’ AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDING OR LEGAL REASONING AND ANY PARTY’S<br>RIGHT TO APPEAL OR TO SEEK MODIFICATION OF RULINGS BY THE ARBITRATORS IS STRICTLY LIMITED.
---	---

ARBITRATION AGREEMENT. ANY AND ALL CONTROVERSIES, DISPUTES OR CLAIMS BETWEEN MAXIM AND THE COMPANY OR THEIR RESPECTIVE REPRESENTATIVES (OTHER THAN APPLICATIONS FOR INJUNCTIVE OR OTHER EQUITABLE RELIEF OR APPLICATION FOR ENFORCEMENT OF A RESOLUTION OR AWARD UNDER THIS SECTION 9) ARISING OUT OF, IN CONNECTION WITH, FROM OR WITH RESPECT TO (a) ANY PROVISIONS OF OR THE VALIDITY OF THIS AGREEMENT OR ANY RELATED AGREEMENTS, (b) THE RELATIONSHIP OF THE PARTIES HERETO, OR (c) ANY CONTROVERSY ARISING OUT OF the Company’s BUSINESS SHALL BE CONDUCTED PURSUANT TO THE COMMERCIAL ARBITRATION RULES OF AAA. ARBITRATION MUST BE COMMENCED BY SERVICE OF A WRITTEN DEMAND FOR ARBITRATION OR A WRITTEN NOTICE OF INTENTION TO ARBITRATE. IF the Company is A PARTY TO SUCH ARBITRATION, TO THE EXTENT PERMITTED BY THE RULES OF THE APPLICABLE ARBITRATION TRIBUNAL, THE ARBITRATION SHALL BE CONDUCTED IN NEW YORK, NEW YORK. THE DECISION AND AWARD OF THE ARBITRATORS(S) SHALL BE CONCLUSIVE AND BINDING UPON ALL PARTIES, AND ANY JUDGMENT UPON ANY AWARD RENDERED MAY BE ENTERED IN THE STATE OR FEDERAL COURTS LOCATED IN NEW YORK COUNTY, OR ANY OTHER COURT HAVING JURISDICTION THEREOF, AND NEITHER PARTY SHALL OPPOSE SUCH ENTRY.

10. Parties. This Agreement has been and is made solely for the benefit of the parties and their respective successors and assigns. Nothing in this Agreement, expressed or implied, is intended to confer or does confer on any person or entity other than the Parties and their respective successors and assigns and, to the extent expressly set forth herein, the Indemnified Parties (as defined on Exhibit A hereto), any rights or remedies under or by reason of this Agreement or as a result of the services to be rendered by Maxim hereunder; provided, that no Indemnified Party (other than Maxim as a direct party to this Agreement) will have any direct rights under this Agreement or Exhibit A hereto (and any actions on behalf of such persons must be taken on their behalf by Maxim) unless they first agree in writing with the Company to be subject to the provisions of Section 18 of this Agreement that apply to Maxim. Neither Maxim nor the Company shall assign any of its obligations hereunder without the prior written consent of the other party (such consent not to be unreasonably withheld, delayed or conditioned), and any purported assignment without such consent shall be null and void ab initio.

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 5 of 9

11. Severability. If provision of this Agreement shall for any reason be determined to be void or unenforceable, any such provision shall be curtailed and limited only to the extent necessary for the remaining terms and provisions to have full force and effect.

12. Review by Counsel. This Agreement has been reviewed by the signatories hereto and their counsel.

13. Credit. Subject to Section 7B, Maxim may, at its own expense, place announcements in financial and other newspapers and periodicals describing its services in connection with the Transaction after public announcement of the definitive agreement for the Transaction. The content of any such announcement shall be subject to the Company’s prior written approval. The Company agrees not to unreasonably withhold or delay such approval.

**14. Limitation of Liability.**Maxim and the Company further agree that neither Maxim nor any other Indemnified Party shall have any liability to the Company, its security holders or creditors, or any person asserting claims on behalf of or in the right of the Company (whether direct or indirect, in contract, tort, for an act of negligence or otherwise) for any losses, fees, damages, liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement or the Advisory Services rendered herein, except to the extent such losses, fees, damages, liabilities, costs or expenses arise out of or are based on any action of or failure to act by Maxim and that are finally and fully judicially determined to have resulted from the gross negligence or willful misconduct of Maxim or any other Indemnified Party.

15. Entire Agreement;Modification; Waiver. This Agreement contains the entire agreement of the Parties with respect to the subject matter hereof and supersedes all prior understandings or agreements with respect thereto. This Agreement may not be altered, amended, changed or modified, nor can any of its provisions be waived, except by written amendment signed by the Parties or as specifically set forth herein. Any waiver or any breach of any of the terms or conditions of this Agreement shall not operate as a waiver of any other breach of such terms or conditions or of any other term or condition, nor shall any failure to insist upon strict performance or to enforce any provision hereof on any one occasion operate as a waiver of such provision or of any other provision hereof or a waiver of the right to insist upon strict performance or to enforce such provision or any other provision on any subsequent occasion.

16. Counterparts. This Agreement may be executed in any number of counterparts and by facsimile transmission (or by transmission of signatures by email attachment), each of which shall be deemed to be an original instrument, but all of which taken together shall constitute one and the same agreement. Facsimile or other electronically scanned and transmitted signatures (including by email attachment) shall be deemed to be original signatures for all purposes of this Agreement.

17. Notices. All notices provided hereunder shall be given in writing and writing and will be effective when delivered (i) in person, (ii) three (3) business days after being sent via registered or certified U.S. Mail, prepaid and return receipt requested, (iii) one (1) business day after being sent prepaid by reputable, nationally recognized overnight courier service or (iv) via facsimile or email, with affirmative confirmation of receipt, in any case, to the party to whom it is addressed at the following addresses or such other address as such party may advise the other in writing in accordance with the requirements of this Section 17:

if to Maxim, to:

Maxim GroupLLC

300 Park Avenue

New York, New York 10022

Attention: James E. Siegel, General Counsel

Tel. No. (212) 895-3508 / Fax No. (212) 895-3860.

If to the Company, to:

ClimateRock

50 Sloane Avenue

London, SW3 3DD, United Kingdom

Attn: Per Regnarsson, Chief Executive Officer

Tel. No. +44 7747 767496

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 6 of 9

With a copy (which shall not constitute notice) to:

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas, 11th Floor

New York, New York 10105

Attn: Barry I. Grossman, Esq.

Email: bigrossman@egsllp.com

18. Trust Waiver. Reference is made to the final prospectus of the Company, dated as of April 27, 2022 and filed with the SEC (File No. 333- 263542) on April 29, 2022 (the “Prospectus”). Maxim understands that The Company has established a trust account (the “ Trust Account” ) containing the proceeds of its initial public offering (the “ IPO” ) and the overallotment securities acquired by its underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of the Company’ s public stockholders (including overallotment shares acquired by the Company’s underwriters), and that, the Company may disburse monies from the Trust Account only as described in the Prospectus, its organizational documents or the Investment Management Trust Agreement entered into in connection with the IPO. For and in consideration of the Company entering into this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Maxim hereby agrees on behalf of itself and its affiliates that, notwithstanding anything to the contrary in this Agreement, neither Maxim nor any of its affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Released Claims”). Maxim on behalf of itself and its affiliates hereby irrevocably waives any Released Claims that Maxim or any of its affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, this Agreement and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever. Maxim agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by the Company and its affiliates to induce the Company to enter in this Agreement, and Maxim further intends and understands such waiver to be valid, binding and enforceable against Maxim and each of its affiliates under applicable law. The provisions of this Section 18 shall survive any expiration or termination of this Agreement and continue indefinitely.

19.Successors and Assigns. The benefits of this Agreement shall inure to the Parties, their respective successors and permitted assigns and to the indemnified parties hereunder and their respective successors and assigns, and the obligations and liabilities assumed in this Agreement shall be binding upon the Parties and their respective successors and permitted assigns. Notwithstanding anything contained herein to the contrary, neither Maxim nor the Company shall assign any of its obligations hereunder without the prior written consent of the other party.

20. Interpretation.

The section headings in this Agreement have been inserted as a matter of reference and are not part of this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) shall be deemed in each case to be followed by the words “without limitation”; and (iii) the words “herein”, “hereto” and “hereby” and other words of similar import shall be deemed in each case to refer to this Agreement as a whole and not to any particular portion of this Agreement. As used in this Agreement, the term: (x) “business day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by Law to close or unable to open, excluding as a result of “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially banking institutions in New York, New York are generally open for use by customers on such day; (y) “person” shall refer to any individual, corporation, partnership, trust, limited liability company or other entity or association, including any governmental or regulatory body, whether acting in an individual, fiduciary or any other capacity; and (z) “affiliate” shall mean, with respect to any specified person, any other person or group of persons acting together that, directly or indirectly, through one or more intermediaries Controls, is Controlled by or is under common Control with such specified person (for the avoidance of doubt, any reference in this Agreement to an affiliate of the Company prior to the closing of a business combination will include its sponsor, U.N. SDG Support LLC.

(Signature Page, ExhibitA)

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 7 of 9

If the foregoing correctly sets forth our agreement with respect to the matters addressed herein, please so confirm by signing and returning one copy of this Agreement. Your signature below shall indicate the Company’s agreement to the terms hereof. We look forward to working with you.

Very truly yours,
MAXIM GROUP LLC
By:	/s/ Justin Rabinowitz
Justin Rabinowitz
Director, Investment Banking
By:	/s/ Clifford A. Teller
Clifford A. Teller
Co-President, Maxim Group

Agreed to and acceptedthis 17th day of August, 2022

ClimateRock
By:	/s/ Per Regnarsson
	Per Regnarsson
	Chief Executive Officer

(Exhibit A Follows)

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 8 of 9

Exhibit A

INDEMNIFICATION PROVISIONS

Capitalized terms used in this Exhibit A shall have the meanings ascribed to such terms in the Agreement to which this Exhibit A is attached. Notwithstanding anything to the contrary contained herein, the provisions of this Exhibit A (these “Indemnification Provisions”) shall in all cases be subject to Section 18 of the Agreement.

The Company agrees to indemnify and hold harmless Maxim and each of the other Indemnified Parties (as hereinafter defined) from and against any and all losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses and disbursements, and any and all actions, suits, proceedings and investigations in respect thereof and any and all legal and other costs, expenses and disbursements in giving testimony or furnishing documents in response to a subpoena or otherwise (including, without limitation, the costs, expenses and disbursements, as and when incurred, of investigating, preparing, pursing or defending any such action, suit, proceeding or investigation (whether or not in connection with litigation in which any Indemnified Party is a party)) (collectively, “Losses”), directly or indirectly, caused by, relating to, based upon, arising out of, or in connection with, Maxim’s activities on behalf of the Company, (the “Agreement”), any breach by the Company of any representation, warranty, covenant or agreement contained in the Agreement (or in any instrument, document or agreement relating thereto, including any agency agreement), or the enforcement by Maxim of its rights under the Agreement or these indemnification provisions, except to the extent that any such Losses are found in a final judgment by a court of competent jurisdiction (not subject to further appeal) (or by the arbitrator pursuant to Section 9 of the Agreement and confirmed by a court of competent jurisdiction not subject to further appeal) to have resulted primarily and directly from the gross negligence or willful misconduct of the Indemnified Party seeking indemnification hereunder. The Company also agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement of Maxim by the Company or for any other reason, except to the extent that any such liability is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) (or by the arbitrator pursuant to Section 9 of the Agreement and confirmed by a court of competent jurisdiction not subject to further appeal) to have resulted primarily and directly from such Indemnified Party’s gross negligence or willful misconduct.

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

ClimateRock<br><br><br><br>August 17, 2022<br><br><br><br>Page 9 of 9

These Indemnification Provisions shall extend to the following persons (collectively, the “Indemnified Parties”): Maxim, its managers, members, officers, and employees. These indemnification provisions shall be in addition to any liability which the Company may otherwise have to any Indemnified Party.

If any action, suit, proceeding or investigation is commenced, as to which an Indemnified Party proposes to demand indemnification, it shall notify the Company with reasonable promptness; provided, however, that any failure by an Indemnified Party to notify the Company shall not relieve the Company from its obligations hereunder. The Company shall have the right to assume and control the defense of a third party claim for which indemnification is sought by providing written notice thereof to the Indemnified Party. The Indemnified Parties shall have the right to retain one separate counsel of their own choice to represent them, and the reasonable out-of-pocket fees, expenses and disbursements of such counsel shall be borne by the Company. Any such counsel shall, to the extent consistent with its professional responsibilities, cooperate with the Company and any counsel designated by the Company. The Company shall be liable for any settlement of any claim against any Indemnified Party (for which indemnification is sought hereunder prior to such settlement) made with the Company’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed). The Company shall not, without the prior written consent of Maxim (such consent not to be unreasonably withheld, conditioned or delayed), settle or compromise any claim, or permit a default or consent to the entry of any judgment in respect thereof, unless such settlement, compromise or consent (i) includes, as an unconditional term thereof, the giving by the claimant to all of the Indemnified Parties of an unconditional release from all liability in respect of such claim (other than customary confidentiality obligations), and (ii) does not contain any factual or legal admission by or with respect to an Indemnified Party or an adverse statement with respect to the character, professionalism, expertise or reputation of any Indemnified Party or any action or inaction of any Indemnified Party.

In order to provide for just and equitable contribution, if a claim for indemnification pursuant to these indemnification provisions is made but it is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification may not be enforced in such case, even though the express provisions hereof provide for indemnification in such case, then the Company shall contribute to the Losses to which any Indemnified Party may be subject (i) in accordance with the relative benefits received by the Company and its stockholders, subsidiaries and affiliates, on the one hand, and the Indemnified Party, on the other hand, and (ii) if (and only if) the allocation provided in clause (i) of this sentence is not permitted by applicable law, in such proportion as to reflect not only the relative benefits, but also the relative fault of the Company, on the one hand, and the Indemnified Party, on the other hand, in connection with the statements, acts or omissions which resulted in such Losses as well as any relevant equitable considerations. No person found liable for a fraudulent misrepresentation shall be entitled to contribution from any person who is not also found liable for fraudulent misrepresentation. The relative benefits received (or anticipated to be received) by the Company and its stockholders, subsidiaries and affiliates shall be deemed to be equal to the aggregate consideration payable or receivable by such parties in connection with the transaction or transactions to which the Agreement relates relative to the amount of fees actually received by Maxim in connection with such transaction or transactions. Notwithstanding the foregoing, in no event shall the amount contributed by all Indemnified Parties exceed the amount of fees previously received by Maxim pursuant to the Agreement.

Neither termination nor completion of the Agreement shall affect these Indemnification Provisions which shall remain operative and in full force and effect. The Indemnification Provisions shall be binding upon the Company, Maxim and their successors and assigns and shall inure to the benefit of the Indemnified Parties and their respective successors, assigns, heirs and personal representatives.

{01134868.DOCX.4}Members FINRA & SIPC

300 Park Ave. * New York, NY 10022 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com

Exhibit 10.5

AMENDMENT NO. 1 TOLETTER AGREEMENT

This First Amendment (the “Amendment”) to the letter agreement dated August 17, 2022 (the “Letter Agreement”) is made and entered into as of the 20th day of September 2022 by and between ClimateRock (the “Company”) and Maxim Group LLC (“Maxim”). The Company and Maxim are herein collectively referred to as the “Parties” with each individually being a “Party.”

WITNESSETH:

Whereas, the Parties entered into that certain Letter Agreement; and

Whereas, the Parties desire to modify certain terms of the Letter Agreement, all as more fully described herein.

Now,therefore, in consideration of the foregoing and the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

1.	Definitions. Capitalized terms used and not otherwise defined herein shall have the meaning ascribed<br>to such terms in the Letter Agreement.
2.	Amendments.
---	---

The following are hereby added as Sections 3(B) and 3(C) of the Letter Agreement (replacing prior Section 3(B)):

B. With respect to any financing undertaken by the Company (or any successor to the Company) during the term of the Agreement, the Company (or any successor of the Company) shall use Maxim as its sole underwriter, placement agent and/or financial advisor with respect to such financings upon the economic terms set forth below, it being understood that such other customary terms and conditions of Maxim’s engagement shall be memorialized under a separate agreement consistent with this Section, and provided, also, that Company shall not be obligated to pay to Maxim any compensation with respect to investors who are introduced by the Target. With respect to any financing, the Company agrees to reimburse Maxim for, or otherwise pay and bear, the expenses and fees incurred by Maxim for the full amount of its reasonable and documented out-of-pocket accountable expenses (which shall include, but shall not be limited to, all fees and disbursements of Maxim’s counsel, travel, lodging and other “road show” expenses, mailing, printing and reproduction expenses, and expenses incurred by Maxim in conducting its due diligence, including background checks of the Company’s officers and directors), up to a maximum of $125,000:

i.	For an issuance of the Company’s senior debt securities, a cash fee payable at any closing equal<br>to two and one-half percent (2.5%) of the gross proceeds received by the Company at such closing;
ii.	For an issuance of the Company’s subordinated and/or mezzanine debt securities, a cash fee payable<br>at each closing equal to four percent (4.0%) of the gross proceeds received by the Company at such closing; and
---	---
iii.	For equity, equity-linked or convertible securities, a cash fee payable at each closing equal to eight<br>percent (8.0%) of the gross proceeds received by the Company at such closing.
---	---

If, within twelve (12) months after the Term, the Company or any successor to the Company completes any public or private offering of equity, equity-linked or debt securities or other capital raising activity from any of the investors who were contacted by Maxim in connection with this Agreement, the Company or any successor to the Company will pay to Maxim upon the closing of such financing or the receipt of such proceeds the compensation set forth in this Section 3(B).

C. The Company acknowledges and agrees that any compensation payable or paid to Maxim hereunder shall not be construed or characterized as compensation to an underwriter within the meaning of the rules of the Financial Industry Regulatory Authority, Inc. The Company hereby recognizes that the fees contemplated by this Agreement do not waive or in any way obviate the Company’s obligation to pay any of the previously agreed upon deferred compensation due and payable to Maxim under the Underwriting Agreement dated April 29, 2022, between Maxim and the Company (the “Underwriting Agreement”).

3.	Reference to and Effect on the Letter Agreement. Except as specifically modified or amended by<br>the terms of this Amendment, the Letter Agreement and all provisions contained therein are, and shall continue, in full force and effect<br>and are hereby ratified and confirmed. All references in the Letter Agreement to itself shall be deemed references to the Letter Agreement<br>as amended hereby.
4.	Counterparts. This Amendment may be executed in any number of separate counterparts, each of which<br>shall be deemed an original and all of which shall be deemed to be one and the same instrument.
---	---
5.	Governing Law. This Amendment shall be governed by the laws of New York without regard to principles<br>of conflict of laws.
---	---
6.	Successors and Assigns. This Amendment shall be binding upon the parties and their respective successors<br>and assigns.
---	---
7.	Headings. Headings in this Amendment are included for convenience of reference purposes only and<br>shall not constitute a part of this Amendment for any other purpose.
---	---

Inwitness whereof, the Parties hereto have executed this Amendment as of the day and year first above written.

CLIMATEROCK
By:	/s/ Per Regnarsson
Name:	Per Regnarsson
Title:	Chief Executive Officer
MAXIM GROUP LLC
By:	/s/ Clifford A. Teller
Name:	Clifford A. Teller
Title:	Co-President
By:	/s/ Justin Rabinowitz
Name:	Justin Rabinowitz
Title:	Director, Investment Banking

Exhibit 10.6

AMENDMENT NO. 2 TOLETTER AGREEMENT

This Second Amendment (the “Amendment”) to the letter agreement dated August 17, 2022, and as amended as of September 20, 2022 (the “LetterAgreement”) is made and entered into as of the 3^rd^ day of October 2022 by and between ClimateRock (the “Company”) and Maxim Group LLC (“Maxim”). The Company and Maxim are herein collectively referred to as the “Parties” with each individually being a “Party.”

WITNESSETH:

Whereas, the Parties entered into that certain Letter Agreement; and

Whereas, the Parties desire to modify certain terms of the Letter Agreement, all as more fully described herein.

1.	Definitions. Capitalized terms used and not otherwise defined herein shall have the meaning ascribed<br>to such terms in the Letter Agreement.
2.	Amendments.
---	---

Section 3(A) of the Letter Agreement is hereby replaced with the following:

A. If the Company Closes a Transaction(s) with a Target(s), during the Term, then the Company shall pay to Maxim, upon Closing of such Transaction(s), a a fee based upon the amount of cash the Company has in Trust immediately prior to consummation of the Transaction plus the amount of cash raised in connection with the consummation of the Transaction and/or contributed to the Transaction (the “Success Fee”),provided that no such fee shall be due if this Agreement is terminated for Cause in accordance with Section 2. If the amount of such cash is less than $50 million, Maxim’s fee shall be equal to $200,000 in cash and an additional $150,000 of common stock of the post-Transaction Company (the “Common Stock”). If the amount of such cash is equal to or greater than $50 million, then the Success Fee shall be $500,000 cash. If the amount of such cash is equal to or greater than $75 million, then the Success Fee shall be $500,000 cash and an additional $500,000 payable in either cash or Common Stock, at the option of the Company. The Common Stock shall be issued to Maxim Partners LLC, shall be valued at the same price per share/exchange ratio as in the definitive Transaction documentation, and it shall have unlimited piggyback registration rights. The Success Fee shall be paid upon the consummation of the Transaction.

3.	Reference to and Effect on the Letter Agreement. Except as specifically modified or amended by<br>the terms of this Amendment, the Letter Agreement and all provisions contained therein are, and shall continue, in full force and effect<br>and are hereby ratified and confirmed. All references in the Letter Agreement to itself shall be deemed references to the Letter Agreement<br>as amended hereby.
4.	Counterparts. This Amendment may be executed in any number of separate counterparts, each of which<br>shall be deemed an original and all of which shall be deemed to be one and the same instrument.
---	---
5.	Governing Law. This Amendment shall be governed by the laws of New York without regard to principles<br>of conflict of laws.
---	---
6.	Successors and Assigns. This Amendment shall be binding upon the parties and their respective successors<br>and assigns.
---	---
7.	Headings. Headings in this Amendment are included for convenience of reference purposes only and<br>shall not constitute a part of this Amendment for any other purpose.
---	---

Inwitness whereof, the Parties hereto have executed this Amendment as of the day and year first above written.

CLIMATEROCK
By:	/s/ Per Regnarsson
Name:	Per Regnarsson
Title:	Chief Executive Officer
MAXIM GROUP LLC
By:	/s/ Clifford A. Teller
Name:	Clifford A. Teller
Title:	Co-President
By:	/s/ Justin Rabinowitz
Name:	Justin Rabinowitz
Title:	Director, Investment Banking

Exhibit 10.7

AMENDMENT NO. 3 TO LETTER AGREEMENT

This Third Amendment (the “Amendment”) to the letter agreement dated August 17, 2022 (the “Letter Agreement”), is made and entered into as of the 4th day of October 2022 by and between ClimateRock (the “Company”) and Maxim Group LLC (“Maxim”). The Company and Maxim are herein collectively referred to as the “Parties” with each individually being a “Party.”

WITNESSETH:

Whereas, the Parties entered into that certain Letter Agreement; and

Whereas, the Parties desire to modify certain terms of the Letter Agreement, all as more fully described herein.

1.	Definitions. Capitalized terms used and not otherwise defined<br> herein shall have the meaning ascribed to such terms in the Letter Agreement.
2.	Amendments.
---	---

The following sentence in Section 2(B) of the Letter Agreement:

“With respect to any financing undertaken by the Company (or any successor to the Company) during the term of the Agreement, the Company (or any successor of the Company) shall use Maxim as its sole underwriter, placement agent and/or financial advisor with respect to such financings upon the economic terms set forth below, it being understood that such other customary terms and conditions of Maxim’s engagement shall be memorialized under a separate agreement consistent with this Section, and provided, also, that Company shall not be obligated to pay to Maxim any compensation with respect to investors who are introduced by the Target.”

Is replaced by the following wording (change highlighted in yellow)

3.	Reference to and Effect on the Letter Agreement. Except as<br> specifically modified or amended by the terms of this Amendment, the Letter Agreement and<br> all provisions contained therein are, and shall continue, in full force and effect and are<br> hereby ratified and confirmed. All references in the Letter Agreement to itself shall be<br> deemed references to the Letter Agreement as amended hereby.
4.	Counterparts. This Amendment may be executed in any number<br> of separate counterparts, each of which shall be deemed an original and all of which shall<br> be deemed to be one and the same instrument.
---	---
5.	Governing Law. This Amendment shall be governed by the laws<br> of New York without regard to principles of conflict of laws.
---	---
6.	Successors and Assigns. This Amendment shall be binding upon<br> the parties and their respective successors and assigns.
---	---
7.	Headings. Headings in this Amendment are included for convenience<br> of reference purposes only and shall not constitute a part of this Amendment for any other<br> purpose.
---	---

In witness whereof, the Parties hereto have executed this Amendment as of the day and year first above written.

CLIMATEROCK
By:	/s/ Per Regnarsson
Name:	Per Regnarsson
Title:	Chief Executive Officer
MAXIM GROUP LLC
By:	/s/ Clifford A. Teller
Name:	Clifford A. Teller
Title:	Co-President
By:	/s/ Justin Rabinowitz
Name:	Justin Rabinowitz
Title:	Director, Investment Banking

Exhibit 10.8

PRIVATE AND CONFIDENTIAL

To the attention of:

Mr. Per Regnarsson

Mr. Abhishek Bawa

ClimateRock

50 Sloane Avenue,

London, SW3 3DD

United Kingdom

London, 11 July 2022

Dear Per and Abhishek,

Pursuant to our recent conversations, we are pleased to confirm the arrangements under which Alantra Corporate Finance, S.A.U. (“ALANTRA”, “we” or “us”) is engaged by ClimateRock, a special purpose acquisition company, with corporate domicile at 50 Sloane Avenue, London, SW3 3DD, United Kingdom (hereinafter, the “Company” or “you”), to act as its financial advisor for the design, negotiation and execution of potential business combinations between the Company and one or more energy transition companies (each of those a “Transaction” and all together, the “Transactions”).

1. Scope of Services

As part of this mandate, ALANTRA will conduct a complete search of suitable Targets (as defined below) for the Company in the renewable energy sector globally. ALANTRA will be the exclusive advisor for Transactions in Europe, Latin America and the Middle East. ALANTRA will be non-exclusive advisor for Transactions in North America, Asia and Africa. For Transactions in North America, Asia and Africa ALANTRA will be the Company’s M&A advisor, also where Transactions are not introduced by ALANTRA.

We will be looking for Targets in the following sectors: onshore and offshore wind generation, solar PV generation, combined heat and power, concentrated solar power, hydropower generation, energy storage and hydrogen.

If a Target or Targets responds positively to our approaches, we shall provide you with transaction advisory services, which will include valuations of the Target(s), evaluations of alternative negotiation strategies, a recommendation of preferred approaches and transaction structures, and the preparation of any business reviews and other analytical work that may be required. On a more detailed basis, our advisory services (the “Services”) will include:

(i)	Finding and identifying one or more potential target companies, for the<br>Company’s business combination (each a, “Target”);
(ii)	Defining procedures concerning<br>the acquisition process at its different stages, and implementing them on your behalf;
---	---

(iii)	Providing operational assistance<br>to the Company’s in-house project team in all matters relating to the Transactions;
(iv)	Serving as a key contact to<br>the seller and its representatives and advisors (in close coordination with the Company’s project team);
---	---
(v)	Requesting, gathering and analyzing<br>information relevant to the Target(s), their markets and the proposed Transactions;
---	---
(vi)	Preparing and reviewing a valuation<br>of the businesses;
---	---
(vii)	Advising on the value and terms<br>of your offer and on appropriate negotiating strategies and deal tactics;
---	---
(viii)	Coordinating external advisors<br>(i.e. accountants, auditors, lawyers and commercial advisors);
---	---
(ix)	Performing and coordinating<br>the due diligence exercise, including reviewing the results of the due diligence undertaken by other professional advisers in the context<br>of the evaluation of the target company/ies;
---	---
(x)	Assisting in the preparation<br>of internal documentation for the Company regarding the Transactions (e.g. time table, contact log, status updates, investment committee<br>decision papers, etc.);
---	---
(xi)	Reviewing and commenting as<br>far as relevant in light of the Services on documentation which will be required to be filed with the Securities and Exchange Commission(“SEC”)
---	---
(xii)	Undertaking the day-to-day<br>management of the Transactions, assisting in the coordination and administration of all external advisers and reporting on progress;<br>and
---	---
(xiii)	Assisting in the negotiation<br>of binding contractual documentation in conjunction with your legal advisers.
---	---

ALANTRA’s advice will be confined to that normally given by a financial adviser in transactions of the nature of the Transactions. We will not be responsible for giving or obtaining commercial advise or special advice or service in areas which are outside our expertise, such as that normally carried out by a legal, accountancy, tax or environmental adviser, or where you will (or customarily would) have other advisers involved.

In providing the Services, ALANTRA may assume that all your directors and officers and employees named by you from whom we receive instructions are duly authorized to give any such instructions and may do anything which is reasonable or necessary either for ALANTRA to perform the Services or to comply with any applicable laws, rules, regulations, authorizations, consents or practices as may be reasonable or appropriate.

2/10

2. Fees

Retainer Fee

The Company will pay ALANTRA USD 15,000 at signing of this Engagement Letter and a Retainer Fee of USD 20,000 per month that is due and payable on the last day of each month for a maximum period of five months.

Should the aggregated Transaction value be above USD 400 million, the Retainer Fee will increase up to USD 40,000 per month with the same maximum five-month period for the payment of any Retainer Fee.

The Retainer Fee will no longer be due after termination of this Engagement Letter. Transaction Success Fee

The mandate could include multiple Transactions and the fees of each will be paid by the Company to ALANTRA on each Transaction Completion as follows.

If a Transaction which is introduced by ALANTRA or by another institution to which no fees are due by the Company (e.g. an institution acting on behalf of a Target) is Completed (as defined below) the Company shall pay ALANTRA a remuneration for its Services (“Transaction Success Fee”) in the form of

a	For the first USD 300,000,000 (THREE HUNDRED MILLION US DOLLARS) of aggregated<br>value of the Transaction , 1.0% of each Transaction purchase price.
a	For the aggregated value of the Transaction above the first USD 300,000,000 (THREEHUNDRED<br>MILLION US DOLLARS), 0.5% of each Transaction purchase price.
---	---

If a Transaction is Completed (as defined below) in North America, Asia or Africa which is not introduced by ALANTRA and such Transaction requires an introductory, co-advisory or similar fee due by the Company, the Company shall pay ALANTRA a Transaction Success Fee in the form of:

a	For the first USD 300,000,000 (THREE HUNDRED MILLION US DOLLARS) of aggregated<br>value of the Transaction, 0.85% of each Transaction purchase price.
a	For the aggregated value of the Transaction above the first USD 300,000,000 (THREE<br>HUNDRED MILLION US DOLLARS), 0.4% of each Transaction purchase price.
---	---

Notwithstanding the above, it is agreed that the Transaction Success Fee will be subject to a minimum of EUR 1,000,000 (ONE MILLION EUROS).

The Transaction purchase price will correspond to the price paid to the sellers of the applicable Target, including cash, debt and equity funded payments.

3/10

Each Transaction Success Fee shall be payable upon consummation of the applicable Transaction (i.e. when the transaction is closed, following fulfillment, if applicable, of conditions precedent) regardless of (i) the calendar for the payment of the price, (ii) how the purchase price is funded, (iii) any deferred payment subsequent to consummation of the Transaction, or (iv) any adjustments to the price of the Transaction subsequent to consummation (“Completion”).

3. Expenses, Invoicing andTaxes

In addition to the fees described in Section 2 above, the Company will reimburse ALANTRA for all reasonable and documented out-of-pocket expenses incurred in connection with providing the Services for the Transactions, which will be billed from time-to-time. Generally, these represent travel, accommodation, document production, telecommunications and courier costs and related matters; provided that (i) no individual expense (or series of related expenses) in excess of USD 10,000 shall be incurred without prior written approval by the Company and (ii) no expenses may be incurred, in the aggregate, in excess of USD 50,000 without prior written approval by the Company.

The Company will pay its own fees and expenses and general Transaction related fees and expenses incurred in connection with providing the Services for the Transaction including without limitation, those related to the Company’s legal counsels and auditors, any due diligence investigations conducted by third parties commissioned by the Company, the cost of any investor presentations, fees, and printing costs.

All amounts payable to ALANTRA under the terms of this letter agreement shall be paid to ALANTRA free and clear of, and without any deduction or withholding for or on account of, any current or future taxes, levies, duties, or charges. Without limiting the foregoing, all amounts payable will be exclusive of value added tax or any other similar taxes (“VAT”). All amounts charged will be invoiced together with VAT, where appropriate.

All amounts payable by the Company hereunder shall be payable within 15 days of presentation of an invoice by ALANTRA. All invoicing will be in Euros.

4. Information, Confidentialityand Publicity

The Company will furnish or cause to be furnished to ALANTRA such information as we believe appropriate to execute the Transactions and will provide ALANTRA with access to the officers, directors, employees, auditors, counsels and other representatives of the Company and its affiliates.

ALANTRA will rely on the accuracy and completeness, without independent verification, of any information we receive in connection with this engagement. We will not independently evaluate or appraise any assets or liabilities that may be involved in this engagement.

The Company will be solely responsible for the content of the information it will furnish to ALANTRA that is used in the course of the Transactions; provided that any information provided on behalf of a Target shall be to the best of the Company’s knowledge. Consequently, it should not be understood that ALANTRA, through the elaboration of the documents regarding the Transactions (hereinafter the “Analysis”), guarantees the completeness or accuracy of the content of such documents.

4/10

The criteria used to prepare the Analysis are based on estimates of future results of the Company and the targets, their businesses and assets and in light of the inherent uncertainties of any information concerning the future, some of these hypotheses might not materialize as defined herein.

Also, the Analysis are based on current economic and market conditions and, in case these vary in the future, they should be revised.

In light of the foregoing, neither ALANTRA nor any of its subsidiaries, officers, directors, employees, auditors, counsels and other representatives accept any responsibility whatsoever for damages or losses that, directly or indirectly, may derive from the decisions that are adopted based on the Analysis, nor of the use that the recipients make of the Analysis except in the case of damages or losses resulting from ALANTRA’s gross misconduct or gross negligence.

ALANTRA acknowledges that, in connection with the Services to be provided pursuant to this letter agreement, certain confidential, non-public and proprietary information concerning the Company, the Targets, any potential business combination and any potential investors in connection therewith (“Company Confidential Information”) has been or may be directly or indirectly disclosed by the Company, a Target or their respective Representatives to ALANTRA or its Representatives. ALANTRA agrees that, without the Company’s prior consent, no Company Confidential Information will be (x) used by ALANTRA or its Representatives other than in connection with performing the Services under this agreement or (y) disclosed, in whole or in part, by ALANTRA or its Representatives to any other person other than: (i) to those Representatives of ALANTRA who need access to such Confidential Information for purposes of performing the Services to be provided hereunder, who are informed of the confidential nature of such information and bound by non-disclosure and non-use obligations consistent with the provisions of this agreement; (ii) to the Company, its Board of Directors or executive officers and each of the Company’s other Representatives bound by confidentiality obligations; or (iii) as may be required by applicable law, regulation, SEC or stock exchange requirement or legal process (“Legal Requirement”). The term “Company Confidential Information” does not include any information: (a) that was already in the possession of ALANTRA or any of its Representatives on a non-confidential basis prior to the time of disclosure to ALANTRA or such Representatives; (b) obtained by ALANTRA or any of its Representatives from a third person which, insofar as is known to ALANTRA or such Representatives after reasonably inquiry, is not subject to any prohibition against disclosure; (c) which was or is independently developed by ALANTRA or any of its Representatives without use of or reference to any Confidential Information or violating any confidentiality obligations under this agreement; or (d) which was or becomes generally available to the public through no fault of or breach of this agreement by ALANTRA or its Representatives. If ALANTRA or its Representative becomes required by Legal Requirement to disclose any Confidential Information, (x) ALANTRA shall provide prompt notice thereof (to the extent permitted by Legal Requirement) to the Company reasonably in advance of any disclosure, (y) ALANTRA will (and will cause its Representatives to) reasonably cooperate (at the sole expense of the Company) with any reasonable request of the Company to seek an order or other remedy to prevent or narrow such disclosure, and (z) if after compliance with clauses (x) and (y) above, such disclosure is still required after giving effect to any successful efforts by the Company to prevent or narrow such disclosure, ALANTRA or its Representative, as applicable, may disclose only that Confidential Information which its counsel advises it is required by Legal Requirement to disclose. For purposes of this letter agreement, the term “Representatives” with respect to any person shall mean such person’s affiliates and its and its affiliate’s respective directors, managers, officers, employees, consultants, shareholders, advisors, appraisers, agents and other representatives.

5/10

ALANTRA acknowledges that U.S. securities laws and other laws prohibit any person who has material, non-public information concerning a public company from purchasing or selling any of its securities, and from communicating such information to any person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities. ALANTRA acknowledges that the confidentiality provisions of this Section 4 shall be deemed to be an agreement to keep the Company Confidential Information in confidence as contemplated by Regulation FD promulgated by the SEC. In addition, ALANTRA acknowledges and agrees that some of the Company Confidential Information (including the fact that discussions between the Company and any Target have been undertaken with respect to a Transaction) may be considered “material non-public information” for purposes of the federal securities laws and that ALANTRA and its Representatives will abide by all securities laws relating to the handling of and acting upon material non-public information of the Company.

Any advice or opinions provided by ALANTRA may not be disclosed or referred to publicly or to any third party except in accordance with our prior written consent, except when required to be disclosed by any supervisory body or authority or by law or regulations. The Company agrees to keep confidential the terms of this engagement.

The Company acknowledges and agrees that ALANTRA may describe or refer to ALANTRA’s involvement in any Transaction resulting from its engagement under this letter agreement and its services rendered in any advertisements placed in financial or other newspapers and journals (at ALANTRA’s expense) and in any pitch, presentation or other such similar marketing materials which ALANTRA uses as part of its ordinary course of financial advisory services, in the web page of the Alantra Group or in its annual reports provided that (i) the intended Transactions are completed, (ii) the Transaction becomes public other than as a result of ALANTRA’s disclose.

The obligations of ALANTRA set forth in this Section 4 shall remain in effect during the term of two (2) years from the date hereof.

5. Full Services Firm

Please note that Alantra Group is engaged in asset management and securities trading and brokerage, as well as providing capital markets and financial advisory services. As required by applicable laws, regulations and necessary and appropriate internal policies, the Alantra Group has in place "Chinese wall" procedures generally separating sales, trading and asset management areas of the firm from financial advisory. Accordingly, in the ordinary course of Alantra Group’s trading, brokerage, financing services and asset management, the Alantra Group may at any time manage, hold long or short positions, and may trade or otherwise effect transactions, for their own account or the accounts of customers, in debt or equity securities or loans of any company that may be involved in the Transaction. It is further agreed that, to the fullest extent permitted by law, this engagement and the transactions contemplated hereunder do not give rise to any duties (including, without limitation, fiduciary, equitable, or contractual) which would preclude or limit in any way the ability of the Alantra Group to provide similar services to other customers, or otherwise to act on behalf of other customers, in relation to matters not directly related to this engagement or the transactions hereunder. The Company hereby acknowledges and agrees that, by reason of law or duties of confidentiality owed to other persons or the rules of any regulatory authority, the Alantra Group may be prohibited from disclosing information to you (or such disclosure may be inappropriate), including information as to the Alantra Group’s possible interests as described in this paragraph and information received pursuant to client relationships.

6/10

6. Delegation and agents

The Company agrees that ALANTRA, after written approval by the Company which not be unreasonably withheld may appoint one or more of its subsidiaries or affiliates or such other person or persons as ALANTRA thinks fit to act as agent, delegate, sub-contractor or otherwise in connection with or pursuant to the Transactions and also agrees that we may authorise such persons to further sub-delegate their appointment. This power of delegation shall be without prejudice to ALANTRA’s responsibility to the Company for the fulfilment of ALANTRA’s obligations. References in this letter agreement to “ALANTRA”, “we” and “us” shall, save where the context otherwise requires, include any such subsidiaries, affiliates, agents, delegates or subcontractors.

7. Term and Termination

This engagement come in full force and effect on the date of signature by both the Company and ALANTRA and may be terminated by the Company or by ALANTRA at any time with or without cause upon 15 days written notice and without any liability or continuing obligation to you or to us (a “Convenience Termination”); or by providing written notice to the other party in the event of gross negligence or gross misconduct by the other party and failure of that party to cure the consequences of such gross negligence or gross misconduct within 10 days after receipt of the notice (a “Cause Termination”); provided that, Section 4 (Information and Confidentiality), Section 9 (Liability and Indemnification), Section 11 (Applicable Law and Jurisdiction), Section 13 (Waiver Against Trust) will remain in full force and effect regardless of any such termination.

ALANTRA will be entitled to receive the Transaction Success Fee while this letter agreement is in force or in the case of a Convenience Termination by the Company or a Cause Termination by ALANTRA, within 12 months of the date of termination of this letter agreement , if you or any of your affiliates effectuates (wholly or substantially) the Transaction contemplated by this letter agreement or any other Transaction(s) having in all material respects a similar effect. For the avoidance of doubt, in the event of a Convenience Termination by ALANTRA or a Cause Termination by the Company, ALANTRA shall not be entitled to any Transaction Success Fee after termination. No termination or expiration of this letter agreement or ALANTRA’s engagement hereunder shall affect the Company’s obligation to reimburse ALANTRA for its accrued expenses incurred in performance of the Services prior to such termination.

8. Exclusivity

While this agreement is in force, you undertake not to entrust to other advisors similar undertakings relating to the Services described in this letter agreement in Europe, Latin America and the Middle East.

7/10

9. Liability and indemnification

Subject to Section 13, the Company agrees to indemnify and hold harmless ALANTRA and its directors, officers, agents, employees, affiliates and controlling parties (each a “Indemnified Party”) from and against any and all losses, claims, damages or liabilities (or actions in respect thereof) relating to the performance by ALANTRA of the Services contemplated by this letter agreement and will reimburse any Indemnified Party for all expenses (including reasonable legal fees and expenses) as they are incurred in connection with investigating, preparing or defending any such action or claim, except where a court of competent jurisdiction has rendered a final judgment that such action or claim resulted from ALANTRA’s wilful misconduct or gross negligence.

ALANTRA will only be liable (whether directly or indirectly, in contract or tort or otherwise) to the Company and any of its affiliates in connection with the Transaction when a court of competent jurisdiction has rendered a final judgment that such action or claim resulted from ALANTRA wilful misconduct or gross negligence. The parties agree to limit the liability of ALANTRA when it has acted with gross negligence or wilful misconduct up to the amount of the fees paid by the Company in accordance with this document. This limitation of responsibility is the result of the negotiations held by the parties, whereby the amount of the fees to be received by ALANTRA has been agreed taking into account the maximum amount which may be claimed to ALANTRA in connection with its liability hereunder. Any responsibility on the side of the ALANTRA shall be assumed by ALANTRA and, accordingly, any responsibility of its group companies and its board members, directors or employees, is hereby expressly assumed by ALANTRA.

Client agrees that ALANTRA cannot be held liable or deemed in default under the present letter agreement for any breach of an obligation arising hereunder, when such failure is solely the responsibility of a third party, which is not under the control of ALANTRA. In addition, ALANTRA’s liability cannot be increased by any agreement made by the Company, with a third party, without the consent of ALANTRA, that limits the liability of that third party.

10. Data Protection

The Company is hereby informed and expressly consents, by signing this agreement, to the processing of the personal data voluntarily provided in the course of the Transaction, as well as of any data which might be provided to ALANTRA, directly or indirectly, for the enforcement of this agreement or regarding the contracting of any service or product, even after the end of the contractual relation, including, if applicable, any communication or international data transfer among members of the Alantra Group which might be made for the purposes specified in our Data Protection Policy^1^ (the “Data Protection Policy”).

Where you provide personal data on behalf of another individual, you are responsible for notifying that individual that you have provided their personal data to us and directing them to our Data Protection Policy so they can see how we will process their personal data . The Company guarantees the accuracy and truthfulness of the personal data provided, undertaking to keep them duly updated and to notify to ALANTRA of any changes.

1	https://www.alantra.com/data-protection-policy/

8/10

By executing this agreement, the Company accepts the processing and communication of its personal data by ALANTRA for the delivery of information and advertising on the Alantra Group products and services. In any case, your consent to the treatment of your data for these purposes is revocable, and you may withdraw your consent or exercise any of the rights mentioned in our Data Protection Policy.

11. Applicable law and jurisdiction

This agreement shall be governed by and construed in accordance with the laws of the United Kingdom. The parties irrevocably agree that the Courts of London, United Kingdom, have the exclusive jurisdiction to settle any disputes which may arise out of or in connection with this letter and that accordingly any suit, action or proceeding arising out of or in connection with this letter may be brought in such courts.

12. Waiver Against Trust

Reference is made to the final prospectus of The Company, dated as of April 27, 2022 and filed with the Securities and Exchange Commission (File No. 333- 263542) on April 29, 2022 (the “Prospectus”). ALANTRA understands that The Company has established a trust account (the “Trust Account” ) containing the proceeds of its initial public offering (the “ IPO” ) and the overallotment securities acquired by its underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of the Company’ s public stockholders (including overallotment shares acquired by the Company’s underwriters), and that, the Company may disburse monies from the Trust Account only as described in the Prospectus, its organizational documents or the Investment Management Trust Agreement entered into in connection with the IPO. For and in consideration of the Company entering into this letter agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, ALANTRA hereby agrees on behalf of itself and its affiliates that, notwithstanding anything to the contrary in this letter agreement, neither ALANTRA nor any of its affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this letter agreement or any proposed or actual business relationship between the Company or its Representatives, on the one hand, and ALANTRA or its Representatives, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Released Claims”). ALANTRA on behalf of itself and its affiliates hereby irrevocably waives any Released Claims that ALANTRA or any of its affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, this letter agreement and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Letter agreement or any other agreement with the Company or its affiliates). ALANTRA agrees and acknowledges that such irrevocable waiver is material to this letter agreement and specifically relied upon by the Company and its affiliates to induce the Company to enter in this letter agreement, and ALANTRA further intends and understands such waiver to be valid, binding and enforceable against ALANTRA and each of its affiliates under applicable law. The provisions of this Section 13 shall survive any expiration or termination of this letter agreement and continue indefinitely.

9/10

13. General

This letter agreement represents the entire agreement between the Company and ALANTRA with respect to this engagement and may only be amended in writing. Each provision of this letter agreement is severable and if any such provision is or becomes invalid or illegal or unenforceable, the remaining provisions will not be affected.

This letter agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute an original of this letter agreement, but all the counterparts shall together constitute the same agreement.

Should the terms and conditions of the present agreement become acceptable to you, please sign and return the copy enclosed.

Before signing this document, please read the basic data protection information given in the Data Protection clause. By signing this document, you c onsent to the processing of your personal data in the terms and conditions stipulated in such clause.

In this letter agreement, the term: (i) “including” (and with correlative meaning “include”) shall be deemed in each case to be followed by the words “without limitation”; (ii) “person” shall refer to any individual, corporation, partnership, trust, limited liability company or other entity or association, including any governmental or regulatory body, whether acting in an individual, fiduciary or any other capacity; and (iii) “affiliate” shall mean, with respect to any specified person, any other person or group of persons acting together that, directly or indirectly, through one or more intermediaries controls, is controlled by or is under common control with such specified person (where the term “control” (and any correlative terms) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities, by contract or otherwise). For the avoidance of doubt, any reference in this letter agreement to an affiliate of the Company prior to the closing of a business combination will include its sponsor, U.N. SDG Support LLC.

Yours sincerely,

Alantra Corporate Finance,S.A.

/s/ Miguel Hernandez Maestro	/s/ Cesar Ciriza Santero
Miguel Hernández Maestro	César Ciriza Santero
Agreed and<br>accepted,
---
ClimateRock
/s/ Per Regnarsson
Per Regnarsson

10/10

Exhibit 10.9

AMENDMENT NO. 1 TO

LETTER AGREEMENT

This Amendment (the "Amendment") to the letter agreement dated July 11, 2022 (the "Letter Agreement"), is made and entered into as of the 3rd day of October 2022 by and between ClimateRock (the "Company"), Alantra Corporate Finance, S.A.U. ("ALANTRA") and U.N. SDG Support Holdings LLC, a Delaware limited liability company with registered office at 251 Little Falls Drive in the City of Wilmington (19808) ("Sponsor Entity") . The Company, Alantra and the Sponsor Entity are herein collectively referred to as the "Parties" with each individually being a "Party."

WITNESSETH:

Whereas, the Parties entered into that certain Letter Agreement in relation to the design, negotiation and execution of a potential business combination between the Company and one or more energy transition companies through a SPAC (the “Transactions”);

Whereas, the Sponsor Entity is sole member of the sponsor of the Company and has tin that capacity benefited from ALANTRA’S services as provided in the Letter Agreement; and

Whereas, the Parties desire to modify certain terms of the Letter Agreement, all as more fully described herein.

1.	Definitions. Capitalized terms used and not otherwise defined herein shall have the meaning<br> ascribed to such terms in the Letter Agreement.
2.	Amendments.
---	---

2.1. Partiesto the Letter Agreement:

The Parties agree that the Sponsor Entity will become a party to the Letter Agreement, and the Sponsor Entity hereby agrees to be bound by the terms and conditions established therein pari passu with the Company.

2.2. Fees

The following are hereby added as Section 2 of the Letter Agreement (replacing prior Section 2):

Retainer Fee

The Retainer Fee will no longer be due after termination of this Engagement Letter.

Transaction Success Fee

The mandate could include multiple Transactions and the fees of each will be paid by the Company to ALANTRA on each Transaction Completion as follows.

If a Transaction which is introduced by ALANTRA or by another institution to which no fees are due by the Company (e.g. an institution acting on behalf of a Target) is Completed (as defined below) the following remuneration will be due to ALANTRA as a remuneration for its Services (“Transaction SuccessFee”)

●	USD 1,600,000 (ONE MLLION SIX HUNDRED THOUSAND US DOLLARS) payable by the Company;
●	USD 1,600,000 (ONE MLLION SIX HUNDRED THOUSAND US DOLLARS) payable by or<br>on behalf of the Sponsor Entity.
---	---

The Transaction Success Fee payment scheme will in any event be subject to a successful KYC procedure of the Sponsor Entity by ALANTRA in accordance with ALANTRA’s standards (the “KYC”), which shall take place and be completed no later than 17 October 2022 (“Long Stop Date”). In the event of unsuccessful KYC before or on Long Stop Date, the Parties agree that the Company will be responsible for the payment of 100% of the Transaction Success Fee to ALANTRA..

In the event of successful KYC, the Company and the Sponsor Entity agree to be joint and severally liable for the payment of the Transaction Success Fee to ALANTRA.

●	For the first USD 300,000,000 (THREE HUNDRED MILLION US DOLLARS) of aggregated value of the Transaction, 0.85% of each Transaction<br>purchase price.
●	For the aggregated value of the Transaction above the first USD 300,000,000 (THREE HUNDRED MILLION US<br>DOLLARS), 0.4% of each Transaction purchase price.
---	---

Notwithstanding the above, it is agreed that the Transaction Success Fee will be subject to a minimum of EUR 1,000,000 (ONE MILLION EUROS).

The Transaction purchase price will correspond to the price paid to the sellers of the applicable Target, including cash, debt and equity funded payments.

Each Transaction Success Fee shall be payable upon consummation of the applicable Transaction (i.e. when the transaction is closed, following fulfillment, if applicable, of conditions precedent) regardless of (i) the calendar for the payment of the price, (ii) how the purchase price is funded, (iii) any deferred payment subsequent to consummation of the Transaction, or (iv) any adjustments to the price of the Transaction subsequent to consummation (“Completion”).

3.	Reference to and Effect on the Letter Agreement. Except as specifically modified or amended by<br>the terms of this Amendment, the Letter Agreement and all provisions contained therein are, and shall continue, in full force and effect<br>and are hereby ratified and confirmed. All references in the Letter Agreement to itself shall be deemed references to the Letter Agreement<br>as amended hereby.
4.	Counterparts. This Amendment may be executed in any number of separate counterparts, each of which<br>shall be deemed an original and all of which shall be deemed to be one and the same instrument.
---	---
5.	Governing Law. This Amendment shall be governed by the laws of United Kindom without regard to<br>principles of conflict of laws.
---	---
6.	Successors and Assigns. This Amendment shall be binding upon the parties and their respective<br>successors and assigns.
---	---
7.	Headings. Headings in this Amendment are included for convenience of reference purposes only and shall not constitute a part<br>of this Amendment for any other purpose.
---	---

In witness whereof, the Parties hereto have executed this Amendment as of the day and year first above written.

[Signature page follows]

CLIMATEROCK
By:	/s/ Per Regnarsson
Name:	Per Regnarsson
Title:	Chief Executive Officer
SPONSOR ENTITY
By:	/s/ Charles Ratelband
Name:	Charles Ratelband
Title:	Sole member

ALANTRA CORPORATE FINANCE, S.A

/s/ Miguel Hernández Maestro	/s/ César Ciriza Santero
Miguel Hernández Maestro	César Ciriza Santero

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICERPURSUANT TO RULES 13a-14(a) AND 15d-14(a)UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TOSECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Per Regnarsson, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q/A of ClimateRock;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
---	---
b.	(Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942);
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
---	---
a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: December 21, 2022	By:	/s/ Per Regnarsson
---	---	---
		Per Regnarsson
		Chief Executive Officer<br><br> <br>(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Abhishek Bawa, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q/A of ClimateRock;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
---	---
b.	(Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942);
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
---	---
a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: December 21, 2022	By:	/s/Abhishek Bawa
---	---	---
		Abhishek Bawa
		Chief Financial Officer<br><br> <br>(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ClimateRock (the “Company”) on Form 10-Q/A for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Per Regnarsson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 21, 2022
---	---	---
	/s/ Per Regnarsson
	Name:	Per Regnarsson
	Title:	Chief Executive Officer<br><br>(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ClimateRock (the “Company”) on Form 10-Q/A for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Abhishek Bawa, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 21, 2022
---	---	---
	/s/ Abhishek Bawa
	Name:	Abhishek Bawa
	Title:	Chief Financial Officer<br><br>(Principal Financial and Accounting Officer)